Podcasts about emory university school

Dr. Patel is the Chief of Cardiology at Vitruvian Health and a board-certified interventional and structural cardiologist. He attended medical school at the Emory University School of Medicine in Atlanta, Georgia, and completed his residency training in internal medicine at the University of California San Francisco in San Francisco, California. He earned his Master in Business Administration degree at Northwestern University-Kellogg School of Management in Evanston, Illinois.He also completed his fellowships in cardiology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, and then further trained in structural and interventional cardiology at the Emory University School of Medicine in Atlanta, Georgia.https://vitruvianhealth.com/services/heart-vascular

Dr. Patel is the Chief of Cardiology at Vitruvian Health and a board-certified interventional and structural cardiologist. He attended medical school at the Emory University School of Medicine in Atlanta, Georgia, and completed his residency training in internal medicine at the University of California San Francisco in San Francisco, California. He earned his Master in Business Administration degree at Northwestern University-Kellogg School of Management in Evanston, Illinois.He also completed his fellowships in cardiology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, and then further trained in structural and interventional cardiology at the Emory University School of Medicine in Atlanta, Georgia.https://vitruvianhealth.com/services/heart-vascular

Dr. Patel is the Chief of Cardiology at Vitruvian Health and a board-certified interventional and structural cardiologist. He attended medical school at the Emory University School of Medicine in Atlanta, Georgia, and completed his residency training in internal medicine at the University of California San Francisco in San Francisco, California. He earned his Master in Business Administration degree at Northwestern University-Kellogg School of Management in Evanston, Illinois.He also completed his fellowships in cardiology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, and then further trained in structural and interventional cardiology at the Emory University School of Medicine in Atlanta, Georgia.https://vitruvianhealth.com/services/heart-vascular

In this throwback episode honoring National Women Physicians Day, host Shikha Jain, MD, with Physicianary's Hansa Bhargava, MD, and Mend the Gap's Dagny Zhu, MD, discuss the evolution of empowering yourself and others and advocacy with a panel of guests. ·       Intro 0:32 ·       What does it mean to empower women in medicine, and what are the ways that we can really empower others to achieve the things that they may not see for themselves?  1:37 ·       What are some ways in which you have empowered or hope to empower women in medicine? Are there tips or skills that have worked well?  4:41 ·       How have you been empowered by others, or have helped others find their voices?  7:37 ·       Do you agree that the conversation is changing toward a cultural shift in empowerment for women in health care? 12:23 ·       What are some challenges facing advocacy and empowerment? […] What do you do when your advocacy work is not being received or it is a struggle to speak up for someone?  17:10 ·       Emphasizing the importance of communication in advocacy work. 22:23 ·       Intro to Physicianary's part 3 on physician burnout and work-life balance. 22:51 ·       Thanks for listening 23:31 Be sure to listen to Part 1 and Part 3 of Healio's Women In Medicine roundtable discussion, streaming everywhere now! Vineet Arora, MD, MAPP (NAM), is a Herbert T. Abelson professor of medicine, vice dean of education in the biological sciences division and dean for medical education at the University of Chicago Pritzker School of Medicine. She is also an elected member of the National Academy of Medicine. She is a founding member of the 501c3 Women of Impact and advisor to the Women in Medicine Summit. Jennifer Bepple, MD, MMCi, is a double board-certified physician in urology and informatics. She is a member of the American Telemedicine Association, American Urologic Association and American Medical Informatics Association and holds a certification from the American Board of Telehealth and the American Board of AI in Medicine. Hansa Bhargava, MD, is Healio's chief clinical strategy and innovation officer. Listen to her Healio podcast, Physicianary. Shikha Jain, MD, FACP, is a board-certified hematology and oncology physician. She is a tenured associate professor of medicine in the division of hematology and oncology, the director of communication strategies in medicine and the associate director of oncology communication & digital innovation at the University of Illinois Cancer Center in Chicago. Mara Schenker, MD, FACS, FAOA, is an orthopedic trauma surgeon at Grady Memorial Hospital. She is double board certified in orthopedic surgery and clinical informatics. She serves as the chief of orthopedics and associate chief medical information officer.  She is an associate professor of orthopedics at Emory University School of Medicine. She serves on multiple boards for medical and digital technology advisory and sits on major national committees for the American Academy of Orthopaedic Surgeons, AAMC, American College of Surgeons and the Orthopaedic Trauma Association. Dagny Zhu, MD, is a cornea, cataract and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. She can be reached on X @DZEyeMD. Listen to her on Healio's Mend The Gap: Equity In Medicine podcast. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Disclosures: The hosts and guests report no relevant financial disclosures.

Many serious medical illnesses are associated with some degree of serum electrolyte abnormality, renal impairment, or both. The neurologist must determine if the patient's neurologic symptoms are related to the renal and electrolyte disturbances or whether a concurrent primary neurologic process is at play. In this episode, Casey Albin, MD, speaks with Eelco F. M. Wijdicks, MD, PhD, FAAN, FACP, FNCS, author of the article "Neurologic Manifestations of Renal and Electrolyte Disorders" in the Continuum® February 2026 Neurology of Systemic Disease issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Wijdicks is a professor of neurology and attending neurointensivist for the Neurosciences Intensive Care Unit at Mayo Clinic in Rochester, Minnesota. Additional Resources Read the article: Neurologic Manifestations of Renal and Electrolyte Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Guest: @EWijdicks Full episode transcript available here

The sale is complete for a Walton County, Ga. industrial warehouse that will become a new detention center for U.S. Immigration and Customs Enforcement. Local officials confirmed the purchase of the rural warehouse, located approximately 40 miles east of Atlanta. But Social Circle city officials say they’re against it, and Gareth Fenley, a local organizer with Indivisible Boldly Blue, shares on “Closer Look” how she plans to fight it. Plus, Atlanta area hospitals say their staff and resources are ready to respond to the 300,000 FIFA World Cup visitors expected here this summer. Preparations have been ongoing for months in advance, including a training simulation involving two patients who entered the U.S. with an infectious disease. Doctors from Grady Hospital, Piedmont Hospital and the Emory University School of Medicine join the program to discuss their plan to keep residents and visitors healthy during the games. Then, a new ProPublica report is linking a conservative researcher to the seizure of Fulton County’s election records. The author tells us about Kevin Moncla, who has long accused Fulton County of election fraud.See omnystudio.com/listener for privacy information.

In a conversation with CancerNetwork®, Manoj Bhasin, PhD, MS, spoke about findings from a study in which he and colleagues developed a single-cell atlas characterizing the dysregulation of the bone marrow immune microenvironment in newly diagnosed multiple myeloma. Findings published in Nature Cancer showed that the immune system has a broad, treatment-independent influence on outcomes in newly diagnosed multiple myeloma.Bhasin began by detailing the background and methodology of his study, in which an Immune Atlas of multiple myeloma helped generate profiles of 1,397,272 single cells from the bone marrow of 337 patients with newly diagnosed disease to characterize immune and hematopoietic cell populations. He also broke down specific analyses of certain aspects of the immune microenvironment, such as signaling evaluations demonstrating active intercellular communication involving a proliferation-inducing ligand and B cell maturation antigen potentially associated with tumor growth and survival.Looking ahead, Bhasin described a need to research additional factors, including those beyond the bone marrow, which may help clinicians further optimize therapeutic strategies for patients with multiple myeloma.“Maybe the biggest thing we want to say from this study is that the immune system is a critical player in the outcome of multiple myeloma, its emergence, and its therapeutic response. It is not a byproduct; it is a major driver of the outcomes,” Bhasin stated. “[Not] all high-risk multiple myeloma lesions are the same. We should look at the immune imprints of them, further comprehensively study them, and then help in designing immune therapies that fix the immune dysregulation that is associated with each cytogenetic alteration [instead of] thinking that all high-risk cytogenetic lesions of myeloma are all the same.”Bhasin is a professor in the Department of Pediatrics and in the Department of Biomedical Informatics at Emory University School of Medicine, and director of Genomics, Proteomics, Bioinformatics and Systems Biology and the Aflac Director of the Single Cell Biology Program at Children's Healthcare of Atlanta.ReferencePilcher WC, Yao L, Gonzalez-Kozlova E, et al. A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma. Nat Cancer. 2026;7:224-246. doi:10.1038/s43018-025-01072-4

Emory Healthcare leaders Dr. Tina-Ann Thompson and Dr. Dan Salinas join us to explain how their “Circle of Care” model is transforming primary care by supporting patients between visits, strengthening accountability, and delivering measurable improvements in patient outcomes across populations.   Through this Circle of Care approach—and in partnership with Guidehealth, which uses an AI-integrated approach to help care teams proactively close care gaps—Emory is improving chronic disease management, care coordination, and follow-through beyond the traditional office visit.   Some of the results include: Dramatic increases in completed annual wellness visits Better blood pressure and diabetes control Improved transitions of care and follow-up after hospital discharge Stronger documentation, reimbursement alignment, and clinician confidence   Check out our full conversation with Dr. Thompson and Dr. Salinas to hear about the importance of shared accountability across care teams and patients, the role of AI-enabled workflows, and how data and humans  can work together to improve access, quality, and trust in primary care.   Dr. Tina-Ann Kerr Thompson is the Senior Vice President for the Primary Care Service Line and Division Director of Family Medicine at Emory University School of Medicine, and Executive Director of the Emory Healthcare Population Health Collaborative.   Dr. Dan Salinas is the Chief Medical Officer and Chief Quality Officer for the Emory Healthcare Population Health Collaborative, and Assistant Professor in the Department of Family and Preventive Medicine at Emory University School of Medicine.   Learn more about the Emory Healthcare Population Health Collaborative: https://news.emory.edu/stories/2024/11/hs_ehc_guidehealth_population_health_collaborative_18-11-2024/story.html   Learn more about Emory Healthcare: https://www.emoryhealthcare.org   Learn more about Guidehealth: https://guidehealth.com   Key Topics 1:45 – A primary care physician's experience caring for patients between visits 4:21 – Accountability and the patient's role in healthcare 6:30 – Primary care focus and evidence-based care 9:03 – Partnering with Guidehealth to support proactive outreach 11:44 – The value proposition of delivering care this way 13:47 – Improved outcomes and better care for all patients 16:04 – Transitions of care and dramatic increases in completed visits 19:52 – Why documentation matters for outcomes and reimbursement 22:40 – Wrapping care around the patient beyond the office visit 27:07 – Fixing access to mental healthcare through integrated networks 29:45 – Helping patients overcome financial and access barriers 32:59 – Addressing loneliness as a health risk 34:04 – Building a true team of decision-makers in patient care

In this episode, we are joined by Dr. Loren Krueger, Associate Professor and Residency Program Director at Emory University School of Medicine. Dr. Krueger shares her path into dermatology, from her training at Duke University and the University of Wisconsin School of Medicine to completing her dermatology residency at NYU, where she served as chief resident. She reflects on her journey into leadership and academic dermatology and offers insight into the Emory Dermatology Residency Program, including advice for students interested in the field and what applicants can expect from training at Emory. We hope you enjoy!Connect with Emory Dermatology and Dr.Krueger:Emory Dermatology Instagram: @emorydermDr. Krueger Instagram : @thecurlmd---DIGA Instagram: @⁠⁠⁠derminterest⁠⁠⁠Today's Host: Shan Francis---For questions, comments, or future episode suggestions, please reach out to us via email at ⁠⁠⁠derminterestpod@gmail.com⁠⁠⁠ ---District Four by Kevin MacLeodLink: ⁠⁠⁠https://incompetech.filmmusic.io/song/3662-district-four⁠License: ⁠https://filmmusic.io/standard-license

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. USDA Dietary Guidelines 2025-2030. Discussion by: Guest:Phillip Leiberman, MDResident Family Medicine Residency Program Jefferson Health - Abington2. The Effect of Substituting Wate for Artificially Sweetened Beverages on Glycemic and Weight Measures in People With Type 2 Diabetes: The Study of Drinks With Artificial Sweeteners (SODAS), a Randomized Trial – Diabetes Care 2025. Discussion by: Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington3. Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation The DECAFRandomized Clinical Trial – JAMA 2025. Discussion by: Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington4. Exercise for the Treatment of Depression. Cochrane Database of Systematic Reviews 2026 Discussion by:Guest:Aaron Sutton - Behavioral Specialist Family Medicine Residency ProgramChief Wellness Officer for Graduate Medical Education Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In today's episode, Neil Iyengar, MD, moderated an OncLive Insights discussion about adverse effect management when using breast cancer therapies targeting the PI3K, AKT, and mTOR pathways. Dr Iyengar is an associate professor in the Department of Hematology and Medical Oncology and co-director of Breast Medical Oncology in the Department of Hematology and Medical Oncology at Emory University School of Medicine; as well as director of Survivorship Services at the Winship Cancer Institute of Emory University in Atlanta, Georgia. He was joined by Heather Moore, CPP, PharmD, a clinical pharmacist practitioner at the Duke Cancer Center Breast Clinic in Durham, North Carolina; and Sarah Donahue, MPH, NP, a nurse practitioner at the University of California San Francisco Health.  In our exclusive discussion, the experts highlighted the importance of early and comprehensive testing (using both tissue and liquid biopsies) for genetic alterations to guide treatment decisions. They also noted strategies for managing diarrhea, including patient education on diet, proactive use of loperamide, and regular monitoring. They also explained that hyperglycemia management should hinge on prophylactic use of metformin or SGLT2 inhibitors, dietary restrictions, and frequent glucose monitoring. Their conversation on rash management included insights about prophylactic antihistamines, patient education on skin care, and involving dermatology for severe cases. Overall, the experts spotlighted the importance of multidisciplinary collaboration and proactive patient education when treating patients with breast cancer.

Clinicians and patients are in a state of prognostic uncertainty when they are unsure about the future course of an illness. By embracing uncertainty while cultivating prognostic awareness, neurologists can serve the critical role of supporting patients and families through the living and dying process. In this episode, Casey Albin, MD, speaks with Robert G. Holloway, MD, MPH, FAAN, author of the article "Managing Prognostic Uncertainty in Neurologic Disease" in the Continuum® December 2025 Neuropalliative Care issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Holloway is the Edward and Alma Vollertsen Rykenboer Chair and a professor of neurology in the department of neurology at the University of Rochester School of Medicine and Dentistry in Rochester, New York. Additional Resources Read the article: Managing Prognostic Uncertainty in Neurologic Disease Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Albin: Hello, this is Dr Casey Albin. Today I'm interviewing Dr Bob Holloway about his article on managing prognostic uncertainty in neurologic disease, which appears in the December 2025 Continuum issue on neuropalliative care. Welcome to the podcast, and please introduce yourself to our audience. Dr Holloway: Hi, Casey, and thank you. Again, my name is Bob Holloway. I'm a clinician and neurologist up in Rochester, New York, and I've been doing both neurology and palliative care for many years. Dr Albin: Well, that's fantastic. And I really wanted to emphasize how much I really enjoyed reading this article. I know that we're going to get into some of the pearls that you offer, but I really want to tell the listeners, like, this is a great one to read because not only does it have sort of a philosophical take, but you also really provide some pragmatic tips of how we can help our patients manage this prognostic uncertainty. But maybe just tell us a little bit, what is prognostic uncertainty? Dr Holloway: Yes, thank you. Well, I think everyone has a sense of what prognostic uncertainty is. And it's just the uncertain futures that we as clinicians and our patients face. And I would just say that a way to summarize it is just, how do we manage the "not yet" of neurologic illness? Dr Albin: I love that. In neurologic illness, there is so much "not yet" and there are so many unknowns. And what I thought was really helpful about your article is you kind of give us three buckets in which we can think about the different types of uncertainty our patients are facing. What are those? Dr Holloway: This is, I think, an area that really is of interest to me, thinking about how to organize the prognostic "not yet" or that landscape. And one way I've tried to simplify it is to think about it as data-centered. And that's the world that we mostly live in as neurologists. That's the probability distributions. We also have kind of system-level uncertainties, and that's the uncertainties that our health system affords for our patients. And then we have, also, the patient-centered uncertainties and the uncertainties that those two prior categories cause for our patients. And that's a big uncertainty that we often don't address. Dr Albin: In reading the article, I was really struck by, we spend a lot of time thinking about data uncertainty. Can we get population-based research? Can we sort of look at prognostication scoring? I live in the ICU, and so we think a lot about these, like, scoring metrics and putting patients into buckets and helping us derive their care based on where their severity index is. And I'm sure that is true in many of the divisions of neurology. But what I did not really appreciate---and I thought you did a really fantastic job of kind of drawing our attention to---is there's a lot of system-centered uncertainty. Can you give us a little bit of examples, like, what is system-based uncertainty? Dr Holloway: I think system-level uncertainties just encompass the practical information gaps that may arise during our healthcare encounter. And a lot of, I think, the uncertainty that our patients face and families, they actually describe it as they feel captive by the uncertainty. And it's just the unknowns, not just what affords from the actual information about the disease and its prognosis in the future, but actually the level of the system, like, who's going to take care of them? How do you manage arranging for nurses to come into the home or all those practical-level uncertainties that the system provides that sometimes we don't do a good job of road-mapping for patients. Dr Albin: Absolutely. Because I feel like we have a little bit of a gap in that often as physicians. Like, the family asks, what will hospice at home look like? Well, you know, that's a question for case management. I think they'll come in and they'll tell you. But it strikes me that that's a real gap of my being able to walk patients through. Will they get home health care? Will they have transportation set up? Will there be a nurse who comes in to check? How often are they available? What's the cost going to be? All of these practical aspects of dealing with an illness that are beyond sort of our scope of knowledge, but probably have a huge practical impact to the patient. Dr Holloway: Without question, every encounter patients wonder about, that kind of future wish landscape that we- all our future-oriented desires and hopes. And so much of that is the practical aspects of our health system, which is often fragmented, kind of unknown, uncertain. And that's a huge source of uncertainty for our patients and families. And then that leads to many other uncertainties that we need to address. Dr Albin: Absolutely. I think another one that we, again, maybe don't spend quite as much time thinking about is this patient-level uncertainty. What's going on there? Dr Holloway: Yeah. So, I think patient-level uncertainty is that uncertainty that they experience when confronted with the two other types of uncertainty: the actual data-centered uncertainty and the system-level uncertainty. And that's that, kind of, very huge kind of uncertainty about what it means for them and their family and their future futures. And that's a source of huge stress and anxiety, and often frankly bordering on dread and fear for our patients and families. That actually gets into very levels of uncertainty that I would call maybe over even in the existential realm. Patient-level uncertainty in the actual existential questions or the fear and the dread or the kind of just unnerving aspect of it is actually even more important to patients than the scientific or data-centered uncertainty that we focus most of our attention on. Dr Albin: Yeah, I think this is, to me, was getting towards that, like, what does the patient care about and how are they coping with what is in many times a really dramatic shift in their life expectancy or morbidity expectations and this sort of radical renegotiation about what it means to have a neurologic illness? And how does that shift their thinking about who they are and their priorities in the world? Is that right? Dr Holloway: One thousand percent, and in fact, I will say---and I think is one of the main take home messages is that, you know, managing prognostic certainty is not an end in itself. It really is to help patients and families adaptively cope to their new and often harsh new reality, that we could help them adapt to their new normal. I think that is one of our main tasks as neurologists in our care teams is to help patients find and ultimately maybe achieve existential or spiritual or well-being even in their new health states. You know, that you certainly often see in the intensive care unit, but we often always see in the outpatient realm as well, and all our other diseases. Dr Albin: I think that's really hard to do. I think those conversations are incredibly difficult and trying to navigate where patients want to be, what would bring meaning, what would bring value. I think many of us struggle to have these pretty real and intense conversations with families about what really is important. And one of the things I really liked about this article is you kind of walk us through some steps that we as clinicians can take to get a little bit more comfortable. Maybe just walk us through, what are some of the things that you have found most helpful in trying to get families and patients to open up about what brings them meaning? How are they navigating this new, really uncertain time in their life? Dr Holloway: Yeah, so I do kind of have a ten-point recommendations of how to help cultivate a more integrated awareness of an uncertain future. I mean, I think the most important thing is actually just recognizing that embracing uncertainty as an amazingly remarkable cognitive tool. I mean, let's face it, uncertainty, when it happens with neurologic illness and disease, is often fearful. It's scary. It kind of changes our world. But on the flip side of it, it's a remarkable cognitive tool that actually can help us find new ways and new paths and new creativity. And I think we can use that kind of opposites to help our patients find new meaning in very difficult situations. So, thinking about uncertainty, kind of being courageous, leaning into it and recognizing that it does create anxieties and fear, but it also can kind of help create new solutions and new ideas to help people navigate. Dr Albin: I was hoping that maybe you could give us an example of, like, how would you do that? If a patient comes in and they're dealing with, you know, a new diagnosis and they're navigating this new uncertainty, what are some of the things that you ask to help them reframe that, to kind of take some of the good about that uncertainty? How do you navigate that? Dr Holloway: One of the other recommendations is actually just resetting the timeline and expectations for these conversations. That it shouldn't be expected that patients should accept their harsh new reality immediately, that it takes time in a trusted environment. And that there's this, like, oscillating nature of hopes and fears and dread, and you've just got to work with them over time. And with time, and once you understand who the patient and family are and understand where they find meaning and where they find, actually, joy in their life, or what actually brings them meaning, you can start recasting their futures into credible narratives in their kind of future landscape in ways that I think can help them enter into their new realities within the, you know, framework of disease management that you can offer them within your healthcare team or your healthcare system or wherever you are in the world and the available resources that you have to offer patients and families. Dr Albin: So, this sounds like a lot to me like active listening and really trying to get to know what is important to the family, what is important to the patient. And I guess probably just creating that space even in that busy clinical environment. Do I have that right? Dr Holloway: You can absolutely do that, right. You know, and honestly, active listening, we are challenged in our busy healthcare system to do this, but I think with the right listening skills and the appropriate ways of paying attention, you can definitely illuminate these possible, kind of future-oriented worlds for patients and help them navigate those new terrains with them. Frankly, I think that's a real new space for us in neurology. We don't think about and train how to create credible narratives for patients and families. We do it on the fly, but I think there's so much more work to do. How do you actually keep, you know, that best-case, worst-case, most likely credible narratives for patients that can help them adapt to their new realities and support them on their new journeys? Dr Albin: I love that best-case, worst-case, most likely case. I find that framework really helpful. But you talk in your article, it's not just about using that best case or worst case or most likely, but it's actually building some forecasting into that and having some real data to kind of support what you're saying. And there's a lot of growth towards actually becoming good as a medical forecaster. Can you describe a little bit, what did you mean by that? Dr Holloway: You're absolutely right. I think, actually, one of the skillsets of becoming and managing prognostic uncertainty is actually becoming a skilled medical forecaster. And it's a really tall order. So, we've got to be both good medical forecasters as well as helping patients adaptively cope to their new reality. But the good medical forecasting is actually now going more quantitative in thinking about the data that's available to help think about the important outcomes for patients and families and then predicting what their probabilities are so you can shape those futures around. So, yes, we do have to have an open mindset. We do have to actually look at the data that's available and actually think about, what are those long-term probabilities and outcomes? And we can be honest about those and even communicate them with families. But it's a really good skill set to have. Dr Albin: Yeah. This to me was a little bit about, how do you bring in the data knowledge that we try to get over time as we develop our expertise? You're developing not just a reliance on population-based data, but in my experience, I have seen this. And that sort of ability to kind of look at the patient in front of you, think about the big picture, but also a little bit about their unique medical comorbidities or prior life experiences. So, some of that database knowledge, and then bringing in and getting to know what is important to the patient. And so, sort of marrying that data-centric/patient-centric mindset. Dr Holloway: I love it. I guess the other way of saying that, too, is we need to think with precision, but communicate in narratives. And it's okay to gently put more precise estimates on our probability predictions with patients and families, what we think is the most likely case, best and worst case. Because patients and families want us to be more precise. We often shy away from it, but- so, it's okay to think in precisions, but we've got to put those in narratives in the most likely, best-, and worst-case scenarios. And don't be afraid if you think in terms of ninety percents, ten percents, fifty percents; most patients and families don't mind that. And what they're telling us is they actually want to hear that, if you are comfortable talking in those terms. Dr Albin: Yeah, absolutely. And giving a sense of the humility to say, like, this is my best guess based on medical data and my experience, I would say, but again, none of us have a crystal ball. And I do think families, as long as you're sort of couching your expectations into the sort of imperfect, but I'm doing my best, really appreciate that. Dr Holloway: They totally do all the time. Just say, I simply don't know for certain, but these are my best estimates. That's a good way of just phrasing that. Dr Albin: Yeah. So powerful. I don't know for certain. And then I wanted to just kind of close out, because there's this one term that you use that I thought was so interesting. And I wanted you to kind of tell our listeners a little bit about what you mean here, which is that, when you're actively open-minded, you're using this, quote, "dragonfly eyes." What do you mean by that? Dr Holloway: So, the dragonfly eyes, as you know, they can look at three sixty around them and they just, they move in all directions. Being actively open minded, I guess the biggest example I would say is, I don't like the term prognostic discordance, which means that there's a difference of subjective estimates of prognosis between patients and families. Being openly minded is actually embracing the potential information that the family has about prognosis and incorporating that into your estimates. So, I wouldn't say it's discordances, per se; I think being really actively open-minded is taking that all in and utilizing that as, you know what, they know more than you do about the patient and their loved ones, and they may have insights that can inform your best estimates of prognosis. So, the true dragonfly prognosticator actually is one who embraces and doesn't consider it discord, but considers it kind of new, useful information that I just need to weigh in so I can help the family in my best professional way in terms of developing a prognosis, whatever the condition may be. Dr Albin: I can imagine this is just so challenging and something that takes a long time to sort of perfect all of this. I think you say right below that, you need a growth mindset to do this because it is hard, and it's going to take an active participation and an active desire to get better at these conversations with our families. Dr Holloway: One thousand percent. You are so right that it takes time, effort, and not feeling like you're being challenged, but that actually you are including them in your entire body of knowledge, that you're just- it's part of all you're collecting. And even, I was on service last week, and I talked to residents and students about that very issue. It's like take their prognosis. And someone who came in, we thought CJB, very sad, tragic case, but we were thinking about what the future may look like and how do we actually work with the family who had very what we thought was unrealistic expectations. I said, well, no, this is not discordance. This is just useful information that we can take understand where they're coming from and incorporate that into the ways we want to build relationships, build trust, and over time we'll get to a point where we hopefully can work with them and have them have that fully integrated awareness of their future. Dr Albin: Yeah, that's beautiful. It really is this ongoing negotiation that really requires so much listening, understanding, and then obviously information and expertise about the data that we're presenting and the likelihood outcome, recognizing that there's a lot of uncertainty in all of this. Which, you know, again, this is kind of a 360 talk. At every level there is uncertainty, and that's what makes it so hard. Dr Holloway: Yeah, you're absolutely right. And actually, even in the article I kind of used the term radical uncertainty as that, no matter how resolvable all this uncertainty is, there will always still remain that radical element of our existence which we have to actually incorporate and be prepared for. And actually, not only of ourselves, but actually for patients and families and helping manage that. Using narratives and credible narratives and kind of ranges of possibilities is the best way to do that in a personalized way. Dr Albin: Well, this has been a fantastic conversation, and I know that we are running a bit short on time. So, as we wrap up and you think about this topic, are there any key take-home messages that you hope our listeners will walk away with? Dr Holloway: I think one main emphasis is that despite all the successes we feel we have in neurology, is that we all have to recognize that prognostic uncertainty is just going to increase in the future. But this is going to be for several reasons. One is that, just, the illness uncertainty of all of our great therapies are just going to be creating more uncertainty for the future. And precision medicine is paradoxical, and that actually it creates more uncertainty. So, I think we need to be prepared that we have to manage prognostic uncertainty better, because it's definitely going to increase. And two, it's what I said earlier, is that actually managing prognostic uncertainty is not an end to itself. It's actually helping patients and families adapt to their new and sometimes harsh new reality and actually help them to ultimately get to a place where maybe either their condition is neither dreaded, but actually they can accept it as their new reality and actually achieve some sort of existential well-being and existential health. I think that we have a lot more to emphasize in this area. And for far too long, we've focused on the certainty aspect of our field and not enough on the uncertainty in the world of medicine to help our patients and families. Dr Albin: And gosh, isn't there just so much uncertainty? And I think this has been beautiful. So, thank you again for coming and sharing your expertise. Dr Holloway: Thank you very much. It's been a pleasure. Dr Albin: For all of our listeners out there, this is a truly fantastic article, and I would just like to direct you to going to read the cases because not only do the cases offer a little bit of practical advice, but there's one that's actually sort of a philosophical discussion about, what does it mean to be alive and confront death? There's some beautiful artwork that's featured as well. So this is just a really unique article, and I'm excited for our listeners to have a chance to check it out. So again, today I've been interviewing Dr Bob Holloway about his article on managing prognostic uncertainty in neurologic disease, which appears in the December 2025 Continuum issue on neuropalliative care. Be sure to check out Continuum Audio episodes from this and other issues. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

This episode of Transmission Interrupted dives deep into the fascinating world of seasonal special pathogens, exploring the reasons why certain infectious diseases emerge and surge at specific times of year. Host Jill Morgan is joined by Dr. Susan McLellan and Dr. Lindsay Busch, two experts in infectious diseases and biocontainment, for a captivating discussion on Nipah virus and Lassa fever. From emergency rooms filled during flu season to the quirky, unexpected ways that bats and rodents drive outbreaks in far-off regions, our guests break down what makes these pathogens so unique. Learn how cultural practices, environmental changes, and climate can influence the risk of transmission, and why understanding "One Health" and anthropology is vital for outbreak control. Perfect for clinicians, public health enthusiasts, and anyone curious about how diseases move through populations, this episode offers practical insight into recognizing risk factors, travel histories, and how global disease surveillance impacts communities everywhere. Packed with real-world stories, unexpected facts, and expert advice for spotting and responding to these high-consequence infections, this episode is not to be missed. Subscribe to Transmission Interrupted for more episodes and resources: netec.org/podcast Questions or ideas for future shows? Email us at info@netec.org. Guests Lindsay Busch, MD Assistant Professor, Medicine, Emory University School of Medicine Associate Medical Director, Emory University Serious Communicable Diseases Unit Critical Care Liaison, Emory Serious Communicable Diseases Program Susan McLellan MD, MPH Director, Special Pathogens Excellence in Clinical Treatment, Readiness, and Education (SPECTRE) University of Texas Medical Branch Host Jill Morgan, RN Emory Healthcare, Atlanta, GA Jill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI). Resources Lassa Fever resources at NETECNipah resources at NETECTransmission Interrupted PodcastNETEC YouTubeSign up for NETEC's Email Newsletter About NETEC A Partnership for Preparedness The National Emerging Special Pathogens Training and Education Center's mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources. Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents...

Nicole Moorman, a top criminal defense attorney based in Atlanta, walks through what it's really like working inside the justice system — from defending people in serious felony and federal cases to the pressure of high-stakes trials and courtroom strategy. Born in Chicago and trained in criminal justice and law at Southern Illinois University, Troy University, and Emory University School of Law, Nicole brings a unique perspective shaped by years of legal experience and time spent as a probation officer and task force agent before becoming a lawyer. She explains how she approaches complex defenses, the ethical challenges defenders face, and why protecting the rights of the accused matters so deeply, with insights drawn from real cases and her career as one of Georgia's most respected advocates. _____________________________________________ #CriminalDefenseAttorney #TrueCrime #JusticeSystem #LegalReality #DefenseAttorney #RealStories #YouTubePodcast #lawandcrime _____________________________________________ Thank you to FACTOR for sponsoring this episode: Head to https://factormeals.com/lockedin50off and use code lockedin50off to get 50% off your first Factor box PLUS free breakfast for 1 year. Offer only valid for new Factor customers with code and qualifying auto-renewing subscription purchase. Make healthier eating easy with Factor. _____________________________________________ Connect with Nicole Moorman: Instagram: https://www.instagram.com/_kingcole_/?hl=en Website: https://moorman-law.com/ _____________________________________________ Hosted, Executive Produced & Edited By Ian Bick: https://www.instagram.com/ian_bick/?hl=en https://ianbick.com/ Shop Locked In Merch: http://www.ianbick.com/shop _____________________________________________ Timestamps: 00:00 Intro: Cooperation, Ethics & the Reality of the Justice System 00:27 Nicole Mormon's Childhood, Family & Early Influences 01:33 Education Path That Led to Criminal Justice 05:44 Why Nicole Chose Criminal Justice 07:01 From Chicago to Atlanta: Becoming a Probation Officer 11:10 First Cases as a Probation Officer & Reality Shock 13:37 Probation, Pretrial Supervision & System Flaws 14:40 Leaving Probation to Attend Law School 16:16 Law School Life & Interning at the DA's Office 17:55 Inside the DA's Office: What Prosecutors Really See 19:58 Starting Her Legal Career & Going Solo 20:35 First Trials, Stress & Emotional Pressure 22:00 Attorney-Client Relationships & Ethical Boundaries 23:38 Choosing Clients & Managing Expectations 24:43 Judges, Prosecutors & Fairness in the Courtroom 26:22 Prosecutor vs Defense Relationships Explained 27:16 State vs Federal Cases: Key Differences 28:53 Target Letters, Indictments & Bond Hearings 31:00 Trial Strategy: When to Push Forward or Slow Down 32:54 Preparing for Trial Mentally & Physically 35:23 Balancing Personal Life During High-Stress Trials 37:32 Trial Tactics, Verdicts & Jury Psychology 40:31 Jury Behavior in High-Profile Cases 42:27 Jury Selection & the Role of Consultants 43:32 Critical Trial Moments & Penalties for Going to Trial 44:53 Sentencing, Judges & the Appeals Process 47:17 Custody Status, Bond & House Arrest Explained 50:48 Biggest Client Misconceptions & Money in the System 53:00 Political Influence on Prosecutors & Charging Decisions 55:46 Diversion Programs, Plea Options & Fairness 57:00 Cooperation, Plea Deals & Informants 59:02 Plea Agreements, Testifying & Subpoenas 01:01:31 Trial Delays & Frustrations with the System 01:02:20 What Nicole Would Change About the Justice System 01:03:10 Advice to Her Younger Self 01:04:28 Life Lessons from a Legal Career 01:05:56 Final Thoughts & Closing Message Learn more about your ad choices. Visit megaphone.fm/adchoices

For two-and-a-half centuries, the United States has faced a challenging world. Some of its responses have made Americans proud. Others have not. CFR asked members of the Society for Historians of American Foreign Relations what they considered the best and worst U.S. foreign policy decisions. In this episode, panelists discuss the results of the project and the evolution of America's role in the world.   Host: David M. Rubenstein, Cofounder and Cochairman, The Carlyle Group; Chairman, Board of Directors, CFR   Guests: Mary L. Dudziak, Asa Griggs Candler Professor of Law, Emory University School of Law; CFR Member   James M. Lindsay, Mary and David Boies Distinguished Senior Fellow in U.S. Foreign Policy, CFR   Christopher M. Nichols, Wayne Woodrow Hayes Chair in National Security Studies and Professor of History, The Ohio State University   Want more comprehensive analysis of global news and events sent straight to your inbox? Subscribe to CFR's Daily News Brief newsletter.   To keep tabs on all CFR events, visit cfr.org/event. To watch this event, please visit it on our YouTube channel: America at 250 Series: The Best and Worst Decisions in U.S. Foreign Policy

When addressing obesity in the clinic, it's common to ask patients to focus on food and exercise. But what if we think upstream of the clinical problem and consider the environments, habits and systems that shape health from the very beginning? In this episode, we sit down with an expert whose research has focused on building resilience against obesity starting early in life. From family dynamics to school and community initiatives, the picture of prevention is complex.  Shari Barkin, MD, is the Pediatrician in Chief at Children's Healthcare of Atlanta. She is also the Chair of the Department of Pediatrics, Executive Director of the Pediatric Institute, and the George W. Brumley Jr. Endowed Professor of Pediatrics at Emory University School of Medicine.  Some highlights from this episode include: How to influence eating behaviors in the first six months of life  The role of community involvement and partnerships in preventing childhood obesity  Translating research into practical strategies  Strong communication methods to engage families successfully  This episode is underwritten by Ovintiv, a proud philanthropic supporter of Charting Pediatrics and the Children's Hospital Colorado Foundation. Ovintiv recognizes that their responsibility begins in the communities where they live and work. They are committed to giving back and building safer and more resilient communities. Ovintiv's generous support has made a monumental difference for our patients and families, from enhancing health outcomes to reducing health disparities.  For more information on Children's Colorado, visit: childrenscolorado.org. 

In this episode of Get Psyched, we're joined by Dr. Mark Rapaport, 2025 President-Elect of the American Psychiatric Association and one of the most influential academic leaders in modern psychiatry.Dr. Rapaport has had a distinguished career spanning several of the nation's leading institutions. He has served as CEO of the Huntsman Mental Health Institute and Chair of the Department of Psychiatry at the Spencer Fox Eccles School of Medicine at the University of Utah; Chair of Psychiatry and Behavioral Sciences at Emory University School of Medicine; Chief Psychiatric Officer for Emory Healthcare; founding Co-Director of the Emory Brain Health Center; Chair of Psychiatry and Behavioral Neuroscience at Cedars-Sinai Medical Center; and Vice Chair of Psychiatry at the David Geffen School of Medicine at UCLA.In addition to his leadership roles, Dr. Rapaport is a highly accomplished researcher with more than 200 peer-reviewed publications. He also co-founded and served as Editor-in-Chief of FOCUS: The Journal of Lifelong Learning in Psychiatry, guiding the journal to address emerging clinical topics — including being the first major psychiatric journal to devote an entire issue to LGBTQ+ and underrepresented minority health concerns.In our conversation, Dr. Rapaport reflects on his upbringing, his family's multigenerational legacy in medicine, and the mentors and patients who shaped his path into psychiatry. We discuss his philosophy of leadership, his passion for academic medicine, and the sometimes winding journey of following one's curiosities across research, teaching, and clinical care.Whether you're a medical student, psychiatry trainee, or clinician thinking about leadership, advocacy, or academic medicine, this episode offers an inspiring and thoughtful look at a career devoted to service, mentorship, and advancing the field. Thank you for listening!We are recruiting for several open roles on the Get Psyched podcast team (Editor, Host, Writer, Producer). Here is the application link:https://docs.google.com/forms/d/e/1FAIpQLSfFL4UapBbRxGWiL-V8KNQZslkZF-Gnzf2zI16cNoreGcEmXA/viewform?usp=sharing&ouid=111781906299228250953Music from #Uppbeat (free for Creators!):https://uppbeat.io/t/cruen/city-streetsLicense code: 2JJVCBQKEE2GJH5N

In this inspiring episode of the Emory University series on Nurse Converse, host Dr. Everett Moss II, CRNA, sits down with three powerful voices from the Emory University School of Nursing—Dr. Beth Ann Swan, Dr. Shawana Moore, and recent graduate Sofi Igyan—to unpack one of the most misunderstood words in nursing: power.Together, they challenge the idea that power is something loud, aggressive, or purely positional. Instead, they explore power as the ability to influence change, whether you're an academic leader, an advanced practice nurse, or a new graduate stepping into the profession for the first time.Listeners will hear:Why power is deeply personal and often situational—shifting with the room you're in, the role you hold, and how others perceive you.How humility and silence can be profound sources of strength, including the concept of the “silent storm” and the impact of knowing when not to speak.The student and new-graduate perspective on power—how embracing agency, mentorship, and opportunities can transform the nursing school and early-career experience.The role of mentorship in cultivating influence and the responsibility to lift others as you rise.How storytelling and social media can serve as powerful platforms when nurses share lived experiences and credible information.Practical advice for nurses at every stage—from flowing like water through challenges, to embracing new opportunities, to navigating imposter syndrome.From redefining influence to owning your voice at any stage of a career, this conversation highlights the many forms of power nurses hold—and how harnessing that power can shape both individual careers and the future of the profession.>>8 Keys to Cultivating Power in Your Nursing CareerJump Ahead to Listen: [00:02:19] Understanding power and influence in nursing [00:04:43] Navigating personal power and professional presence [00:10:15] Influence within nursing's power structures [00:14:32] Elevating student confidence and empowerment [00:20:17] How nursing students shape conversations online [00:21:24] Examining influencers and credibility in nursing [00:26:01] Storytelling as a catalyst for impact [00:30:09] Mentorship as a foundation for future leaders [00:37:01] Staying open to unexpected opportunities [00:40:05] Adapting and “flowing like water” in your career [00:42:15] Growth through professional and personal challenges [00:47:00] Books and ideas that inspire empowered nursing practice For more information, full transcript and videos visit Nurse.org/podcastJoin our newsletter at nurse.org/joinInstagram: @nurse_orgTikTok: @nurse.orgFacebook: @nurse.orgYouTube: Nurse.org

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Candesartan for Migraine Prophylaxies. The Lancet 2025 . Discussion by:Guest:Max Schidt, MDResident - Family Medicine Residency ProgramJefferson Health - Abington2. One vs two dose HPV vaccination for prevention of HPV infection – The New England Journal of Medicine 2025. Discussion by:Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington3. The Surpass CVOT trial for prevention of MACE in people with Diabetes – The New England Journal of Medicine 2025. Discussion by:Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington4. The New American Cancer Society Guidelines for Screening for cervical cancer – that includes self swab for HPV. Discussion by:Guest:Amy Clouse, MD Associate Director - Family Medicine Residency Program Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

In this podcast episode, we are joined once again by Dr. Rainey Horwitz, a first-year urology resident at Emory University School of Medicine. She's passionate about sexual health and wellness and is dedicated to destigmatizing conversations about sex between patients and healthcare providers. As a returning guest, Dr. Horwitz brings fresh insights and clinical perspective to an evolving and often misunderstood topic: low sexual desire in men. For more free erectile dysfunction education and resources, please visit: https://eiqmen.com/   Mark Goldberg helps men resolve erectile dysfunction. He offers individual, one-on-one services to men throughout the world through a secure, telehealth platform. It's 100% confidential. You can visit the Center for Intimacy, Connection and Change website to schedule a free consultation: https://centericc.com/

Dr. Noor Al-Shibli, a board-certified OB-GYN and maternal-fetal medicine fellow, shares how remarkable advancements in antiretroviral therapy have drastically reduced HIV transmission rates during pregnancy. Listen to discover the collaborative efforts of health care professionals and community advocates in supporting pregnant individuals living with HIV and learn about the evolving guidelines that empower shared decision-making in infant feeding. This is an inspiring conversation on breaking barriers and fostering hope in maternal health. Meet our guests: Noor Al-Shibli, MD Read More Dr. Noor Al-Shibli is a board-certified OBGYN and third year Maternal Fetal Medicine Fellow at Emory University School of Medicine. She received her undergraduate and medical degrees from the University of Tennessee and completed her OBGYN residency training at Duke University. Throughout her time at Emory, she has cared for high-risk obstetrics patients at Grady Memorial Hospital, including a specialized high-risk obstetrics clinic for pregnant individual living with HIV. Her clinical and research interests include infectious diseases, maternal nutrition, and community health. Noor has a passion for educating and empowering her patients about their reproductive health. Episode Resources Dr. Michael Lindsay NIH Perinatal HIV Guidelines CDC HIV Hotlines and Warmlines Perinatal HIV Hotline: 1-888-448-8765 (24 hours, seven days a week) Ryan White Program Locator AWHONN Infectious Disease Resources AWHONN HIV Resources AWHONN Respectful Maternity Care (RMC) The post Breaking Barriers: Advances in Perinatal HIV Care appeared first on AWHONN.

  Episode description: We continue our campaign to #EndNeurophobia, with the help of Dr. Aaron Berkowitz. This time, Sarah presents a case to Sebastian and Vijay.  Sarah Blaine (@sarahkblaine) Sarah Blaine is an MD/MSc student at Emory University School of Medicine applying into neurology residency. She isfrom SouthernCalifornia and went to UC Berkeley for her undergraduate… Read More »Episode 435: Neurology VMR – Weakness and numbness

In this episode of the PRS Global Open Keynotes Podcast, Dr. Paul Ghareeb discusses the important of research productivity (presentations and publications) to the career prospects of medical students, residents and attending surgeons alike.   This episode discusses the following PRS Global Open article: "How to Boost Research Productivity: An American Council of Educators in Plastic Surgery Cross-sectional Survey" by Shannon Su, Ambika Menon, Christopher Stewart, Hannah Jones and Paul Ghareeb. Read it for free on PRSGlobalOpen.com: https://journals.lww.com/prsgo/fulltext/2025/11000/how_to_boost_research_productivity__an_american.5.aspx Dr. Paul Ghareeb is an Assistant Professor in the Division of Plastic and Reconstructive Surgery at the Emory University School of Medicine in Atlanta, Georgia Your host, Dr. Damian Marucci, is a board-certified plastic surgeon and Associate Professor of Plastic Surgery at the University of Sydney in Australia. #PRSGlobalOpen; #KeynotesPodcast; #PlasticSurgery; Plastic and Reconstructive Surgery- Global Open

In this episode, we speak with Dr. Stan Sonu, Associate Professor of Internal Medicine and Pediatrics at Emory University School of Medicine and Medical Director for Child Advocacy at Children's Healthcare of Atlanta. Dr. Sonu shares his insights on adverse childhood experiences (ACEs), relational health, and trauma-informed care, focusing on how clinicians and schools can support resilience and wellbeing in children and families.We dive into Dr. Sonu's paradigm of “what's strong with you” instead of “what's wrong with you?”, and explore the fascinating concept of systemic empathy—how organizations and systems can create environments that nurture and protect children's relational health.Dr. Sonu also highlights innovative programs like Strong 4 Life at Children's Healthcare of Atlanta and the Health-Law Partnership (HeLP), a collaborative addressing health-harming legal issues for low-income families.He references valuable resources for clinicians, educators, and families, including the work of Dan Siegel, Interpersonal Neurobiology, and community support services at Grady Memorial Hospital.Listeners will gain actionable ideas for integrating trauma-informed principles into their own practice, classrooms, or organizations, and be inspired to shift from focusing on deficits to recognizing and building on strengths in children and families.Resources Mentioned in This Episode:https://www.strong4life.com/en/our-experts/stan-sonuGrady Memorial HospitalDan Siegel Books & ResourcesInterpersonal Neurobiology ResourcesHealth-Law Partnership (HeLP)

Guest: Rachel Conrad, MA, CCC-SLPEarn 0.10 ASHA CEU for this episode with Speech Therapy PD: https://www.speechtherapypd.com/courses/embracing-lived-experiencesIn the first episode of 2025, Michelle is joined by Jaclyn Pederson, MHI, CEO of Feeding Matters, and William Sharp, PhD, Director of Children's Multidisciplinary Feeding Program (Atlanta, GA) and Professor at Emory University School of Medicine, to lay the foundation for a year of combining passion, advocacy, and learning. These guests share their expertise and highlights from a recent journal publication on how the diagnoses of “Pediatric Feeding Disorder” and “Avoidant Restrictive Feeding Intake Disorder” are individualistic while simultaneously overlapping to capture the unique needs of the little ones on our caseloads. Additionally, they share practical insight into the roles and responsibilities of various team members, such as the SLP and the psychologist, in evaluating and treating these little ones as part of an interprofessional practice team.About the Guest: Rachel Conrad, MA, CCC-SLP, is the owner of Bite and Bloom Therapy, LLC, under The Mindful Collective, where she specializes in pediatric feeding and swallowing, ARFID, AAC, and sensory-based therapy. She serves as the Chair of the Feeding Matters Research Consortium, a patient- and family-centered research initiative partially funded by the Patient-Centered Outcomes Research Institute (PCORI). Rachel brings a unique perspective to her work, combining her professional expertise with her lived experience of pediatric feeding differences and ARFID. She collaborates with The Village, a perinatal and eating disorder provider group, and participates in national advocacy and education initiatives to improve early intervention and interdisciplinary care for children with feeding differences. Rachel has delivered presentations and talks on best practices for evaluating and treating medically complex children with feeding and swallowing disorders. She is passionate about creating spaces where patients and families feel truly heard, seen, and valued in discussions about feeding differences. She is a member of the American Speech-Language-Hearing Association (ASHA) and the Kansas Speech-Language-Hearing Association (KSHA) and is committed to advancing awareness, research, and best practices in pediatric feeding and swallowing. Rachel bridges the gap between research, clinical practice, and lived experience to support children and families navigating feeding differences.Show Notes:Bite & Bloom Therapy: https://www.mindfulcollectivegroup.com/rachel-conradFeeding Matters: https://www.feedingmatters.orgFind Assistance: https://www.findhelp.org

The mental health system didn't start out fair — and in many ways, it still isn't. In this powerful episode, Dr. Nicole Washington sits down with fellow psychiatrist Dr. Leesha Ellis-Cox to unpack the long, painful history that continues to shape the experiences of Black Americans seeking mental health care. From the horrifying “diagnosis” of drapetomania in the 1800s to the Tuskegee Syphilis Study, they trace how mistrust, stigma, and systemic bias became woven into the Black community's relationship with psychiatry.But they don't stop there. Dr. Nicole and Dr. Leesha explore the research showing that Black and Hispanic people are 3 to 4 times more likely to be misdiagnosed with schizophrenia instead of bipolar disorder — a mistake that can derail treatment, worsen symptoms, and put lives at risk.Listener takeaways the historical roots of racial disparities in psychiatric diagnosis why Black Americans are more likely to be misdiagnosed with schizophrenia how stigma and generational trauma shape attitudes toward treatment practical steps to find culturally humble, affirming providers Most importantly, they offer real, actionable advice: how to find culturally affirming care, how to navigate bias in the system, and how Black and other communities of color can break generational silence around mental health. This conversation is validating, eye-opening, and deeply empowering. Listen now!   Our guest, Dr. Leesha Ellis-Cox, affectionately known as Dr. Leesha, is a double board certified child, adolescent, and adult psychiatrist. She earned both her Bachelor of Science and Doctor of Medicine degrees from the University of North Carolina at Chapel Hill and completed her general psychiatry residency training, child and adolescent psychiatry fellowship, and community mental health/public psychiatry fellowship at Emory University School of Medicine in Atlanta. Since 2009, she has lived and worked in Alabama and is the medical director at Central Alabama Wellness, a community mental health center located in metro Birmingham. Our host, Dr. Nicole Washington, is a native of Baton Rouge, Louisiana, where she attended Southern University and A&M College. After receiving her BS degree, she moved to Tulsa, Oklahoma to enroll in the Oklahoma State University College of Osteopathic Medicine. She completed a residency in psychiatry at the University of Oklahoma in Tulsa. Since completing her residency training, Dr. Nicole has spent most of her career caring for and being an advocate for those who are not typically consumers of mental health services, namely underserved communities, those with severe mental health conditions, and high performing professionals. Through her private practice, podcast, speaking, and writing, she seeks to provide education to decrease the stigma associated with psychiatric conditions. Find out more at DrNicolePsych.com. Our host, ⁠Gabe Howard⁠, is an award-winning podcast host, author, and sought-after suicide prevention and mental health speaker, but he wouldn't be any of those things today if he hadn't been committed to a psychiatric hospital in 2003.Gabe also hosts Healthline's ⁠Inside Mental Health⁠ podcast has appeared in numerous publications, including Bipolar magazine, WebMD, Newsweek, and the Stanford Online Medical Journal. He has appeared on all four major TV networks, ABC, NBC, CBS, and FOX. Among his many awards, he is the recipient of Mental Health America's Norman Guitry Award, received two Webby Honoree acknowledgements, and received an official resolution from the Governor of Ohio naming him an “Everyday Hero.” Gabe wrote the popular book, "⁠Mental Illness is an Asshole and other Observations⁠," available from Amazon; signed copies are available ⁠directly from the author⁠ with free swag included! To learn more about Gabe, or to book him for your next event, please visit his website, ⁠gabehoward.com⁠. Learn more about your ad choices. Visit megaphone.fm/adchoices

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. FDA change in Boxed Warning Label for Hormone Replacement Therapy.  Discussion by:Guest:Anupriya Grover Wenk, DOFaculty - Family Medicine Residency ProgramJefferson Health - Abington2. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke – The New England Journal of Medicine 2025. Discussion by:Guest:Neil Skolnik, MD Professor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson University Associate Director - Family Medicine Residency Program Jefferson Health – Abington3. AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program – JAMA. Discussion by:Guest:Neil Skolnik, MDProfessor of Family and Community MedicineSidney  Kimmel  Medical College Thomas Jefferson UniversityAssociate Director - Family Medicine Residency ProgramJefferson Health – Abington4. Incremental effect of healthy lifestyle habits when taking GLP-1 RA medications on Cardiac Risk Reduction.  Discussion by:Guest:Joe Gonella, MDResident– Family Medicine Residency ProgramJefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Send us a textEpisode 210 of Your Child is Normal is a conversation discussing everything you've ever wondered about UTIs! It's common for kids to occasionally feel discomfort when they pee — but how do you know when it's something that needs more attention, like a urinary tract infection?In this episode, pediatrician Dr. Jessica Hochman talks with pediatric urologist Dr. Andrew Kirsch, author of The Ultimate Bedwetting Survival Guide, about everything parents should know about UTIs in children — from the most common symptoms to when to see a doctor.They discuss:How UTIs present differently in babies vs. older kidsWhy constipation is one of the biggest risk factorsWhen testing and antibiotics are necessaryWhat really works for prevention — hydration, bathroom habits, and (maybe!) cranberry extractCommon myths, like whether bubble baths cause infectionsIf your child has ever had burning with urination, frequent accidents, or unexplained fevers, this episode will help you feel more confident about what to do next.Dr. Kirsch  completed both a residency in general surgery and urology at the Columbia University and he completed his fellowship in pediatric urology at the Children's Hospital of Philadelphia.He has written extensively with an emphasis on vesicoureteral reflux diagnosis and management, publishing nearly 300 journal articles and book chapters. Currently, Dr. Kirsch is a professor and chief of pediatric urology at Emory University School of Medicine and a partner at Georgia Urology.   Dr. Kirsch has been named in Atlanta Magazine's Best Doctors and The Best Doctors in America list, representing the top 5% of doctors in America.Your Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube channel: Ask Dr Jessica If you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditi...

From November 6, 2024: For today's special episode, Lawfare General Counsel and Senior Editor Scott R. Anderson held a series of conversations with contributors to a special series of articles on “The Dangers of Deploying the Military on U.S. Soil” that Lawfare recently published on its website, in coordination with our friends at Protect Democracy.Participants include: Alex Tausanovitch, Policy Advocate at Protect Democracy; Laura Dickinson, a Professor at George Washington University Law School; Joseph Nunn, Counsel in the Liberty and National Security Program at the Brennan Center; Chris Mirasola, an Assistant Professor at the University of Houston Law Center; Mark Nevitt, a Professor at Emory University School of Law; Elaine McCusker, a Senior Fellow at the American Enterprise Institute; and Lindsay P. Cohn, a Professor of National Security Affairs at the U.S. Naval War College. Together, they discussed how and why domestic deployments are being used, the complex set of legal authorities allowing presidents and governors to do so, and what the consequences might be, both for U.S. national security and for U.S. civil-military relations more generally.To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/lawfare-institute.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

In today's episode, we had the pleasure of speaking with Kevin Kalinsky, MD, MS, FASCO, about the evolving treatment paradigm for hormone receptor (HR)–positive breast cancer post-CDK4/6 inhibition, as well as the need for more advanced therapies to improve patient outcomes in this setting. Dr Kalinsky is a professor and director in the Division of Medical Oncology of the Department of Hematology and Medical Oncology at Emory University School of Medicine, as well as the director of the Glenn Family Breast Center and the Louisa and Rand Glenn Family Chair in Breast Cancer Research at Winship Cancer Institute in Atlanta, Georgia. In our exclusive interview, Dr Kalinsky discussed combination therapies that have shown promise for the management of HR-positive breast cancer following endocrine therapy, factors influencing treatment selection for patients who have received prior CDK4/6 inhibition, best practices for genomic testing in this population, and breast cancer research highlights from the 2025 ESMO Congress.

On this episode of Transmission Interrupted, host Jill Morgan sits down with Dr. John Horton, Vice Chair of Clinical Affairs for Gynecology and Obstetrics at Emory, to explore one of the most challenging intersections in healthcare: special pathogens and pregnancy. From emerging threats like Ebola and Marburg to familiar concerns like measles and chickenpox, they dive deep into what makes caring for pregnant patients so uniquely complex in the face of infectious diseases.Join us for a candid and insightful conversation on the evolving best practices for labor and delivery in high-risk situations. Dr. Horton shares lessons learned on the front lines, why compassion and humanity matter as much as protocol, and practical advice on infection prevention, disaster drills, and protecting both patients and healthcare workers.Whether you're in obstetrics, infectious disease, emergency preparedness, or just curious about what makes pregnancy and pathogens such a tough clinical challenge, this episode is packed with fresh insights and actionable takeaways.GuestJohn Patrick Horton, MD, MBAVice Chair of Clinical AffairsGynecology and Obstetrics DepartmentEmory UniversityDr. John Horton is the Vice Chair of Clinical Affairs for Emory University's Department of Gynecology and Obstetrics. He also serves as Emory Healthcare's Division Director for General Gynecology and Obstetrics, and Interim Operations Director for the Gynecologic Specialties Division. Additionally, Dr. Horton is the Director of the Obstetric Rapid Response Team at Emory Healthcare and is Associate Professor at the Emory University School of Medicine Department of Gynecology and Obstetrics. HostJill Morgan, RNEmory HealthcareJill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI).ResourcesNETEC:https://netec.orgNETEC Resource Library:https://repository.netecweb.org/NETEC YouTube:https://www.youtube.com/@TheNETECNETEC Newsletter:https://netec.org/newsletter-sign-up/Transmission Interrupted:https://netec.org/podcast/About NETECA Partnership for PreparednessThe National Emerging Special Pathogens Training and Education Center's mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources.Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems.For more information visit NETEC on the web at www.netec.org.NETEC...

Those who identify as pro-immigration and pro-nationalist are often at odds with one another.  But what if a healthy dose of nationalism is the very thing that could bolster our immigration?  Nathan Brown and Robert Haglund argue in their new book Rescuing the American Project that "much of the dysfunction in contemporary American politics is a consequence of the failure by our elites to understand the crucial relationship between immigration and nationalism."   Nathan and Robert join Saving Elephants host Josh Lewis to explore the history and controversy of immigration in America, what the Left and the Right get wrong about immigration, what's meant by "nationalism", and to what degree America's lack of faith in our institutions makes immigration reform challenging.   About Nathan Brown From the book Nathan Brown is an immigration lawyer in Fresno, California and a former Republican candidate for Congress.  He has a bachelor's degree from Brigham Young University with majors in history and economics and a law degree from Emory University School of Law.   About Robert Haglund From the book Robert Haglund is a conservative talk radio producer, former Arabic cryptologic linguist for Air Force Intelligence, and veteran of the War in Afghanistan.  

Following a fruitful European Society of Medical Oncology (ESMO) Congress 2025 for gastrointestinal malignancies, CancerNetwork® organized an X Spaces discussion hosted by 3 experts. They were Nicholas J. Hornstein, MD, an assistant professor at the Donald and Barbara Zucker School of Medicine of Hofstra University and Northwell Health; Timothy Brown, MD, an assistant professor in the Department of Internal Medicine and the associate program director of the Hematology & Oncology Fellowship at UT Southwestern Medical Center; and Udhayvir S. Grewal, MD, an assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Each doctor focused on a specific disease type, highlighting the most important abstracts in colorectal cancer, pancreatic neuroendocrine tumors (NETs), and upper gastrointestinal cancers. The Phase 3 MATTERHORN Trial (NCT04592913) Results from MATTERHORN demonstrated that adding durvalumab (Imfinzi) to 5-fluorouracil, leucovorin (folinic acid), oxaliplatin, and docetaxel (FLOT) improved overall survival (OS) compared with FLOT plus placebo in patients with resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma, regardless of pathological status.1 In the intention-to-treat population, the median OS was not reached in either arm, and the hazard ratio (HR) was 0.78 (95% CI, 0.63-0.96; P = .021). Notably, the improvement was observed regardless of PD-L1 status; in patients with PD-L1–positive disease, the HR was 0.79 (95% CI, 0.63-0.99), and in patients with PD-L1–negative disease, the HR was 0.79 (95% CI, 0.41-1.50). “This, I believe, will seal durvalumab plus FLOT as the standard of care for resectable [gastric/GEJ] cancers,” said Brown. The Observational ASPEN Study (NCT03084770) The ASPEN study showed that active surveillance was a safe approach for patients with low-grade, asymptomatic, nonfunctioning pancreatic neuroendocrine tumors (NETs) fewer than 2 centimeters in size.2 Of the 1000 patients enrolled in the trial, 20 patients died, of whom 18 underwent active surveillance and 2 underwent surgery. Nineteen of the deaths were unrelated to pancreatic NETs; 1 death in the surgery arm was related to a pancreatic NET. After surgery, 5 patients had disease relapse or progression. With a median follow-up of 42 months (IQR, 25-60), the OS analysis showed a P value of 0.530.  “This really settles the debate on whether or not to surgically operate on patients with a [pancreatic NET] size of [fewer] than 2 centimeters and shows that active surveillance is a safe option for these patients with pancreatic NETs [fewer] than 2 centimeters in size and non-functional NETs,” said Grewal.  Data From the Phase 2/3 FOxTROT (NCT00647530) and Phase 2 NICHE-2 (NCT03026140) Trials Neoadjuvant nivolumab (Opdivo) plus ipilimumab (Yervoy) achieved a clinically meaningful and statistically significant improvement in long-term outcomes, including responses and survival, compared with chemotherapy strategies in patients with mismatch repair deficient (dMMR) or microsatellite instability–high (MSI-H) locally advanced colon cancer.3 In NICHE-2, neoadjuvant nivolumab plus ipilimumab achieved a 3-year disease-free survival (DFS) rate of 100% compared with 80% (95% CI, 73%-85%) with all chemotherapy strategies in FOxTROT (P

Today on Sauna Talk, we are joined by the dynamic duo of researcher from Emery University, Deanna Kaplan and Roman Palitsky. Deanna Kaplan Deanna Kaplan, PhD is a clinical psychologist with expertise in digital health technologies. She has more than a decade of experience using wearable and smartphone-based technologies to study the dynamics of health processes and clinical change during daily life. Her research is grounded in a whole-person (bio-psycho-social-spiritual) model of health, and much of her work focuses on investigating the dynamics of change of integrative interventions, such as psychedelic-assisted therapies and contemplative practices. Dr. Kaplan is the Director of the Human Experience and Ambulatory Technologies (HEAT) Lab, a multidisciplinary collaboration between the Department of Family and Preventive Medicine and Emory Spiritual Health. More information about the HEAT Lab is here. Dr. Kaplan is the co-creator and Scientific Director of Fabla, an unlicensed Emory-hosted app for multimodal daily diary and ecological momentary assessment (EMA) research. Fabla is an EMA app that can securely collect voice-recorded, video-recorded , and photographic responses from research participants. More information about Fabla is here. Dr. Kaplan holds an adjunct appointment in Emory's Department of Psychology and is appointed faculty for several Emory centers, including the Winship Cancer Institute, Emory Spiritual Health (ESH), the Emory Center for Psychedelics and Spirituality (ECPS), and the Advancement of Diagnostics for a Just Society (ADJUST) Center. She also holds an appointment as an adjunct Assistant Professor at Brown University in affiliation with the Center for Digital Health. Dr. Kaplan received her PhD in Clinical Psychology from the University of Arizona, completed her predoctoral clinical internship at the Alpert Medical School of Brown University, and completed a postdoctoral research fellowship at Brown University, where she received an F32 National Research Service Award (NRSA) from the National Institutes of Health (NIH). Her research is funded by the NIH, the Health Resources Services Administration (HRSA), the Georgia Clinical and Translational Science Alliance, the Tiny Blue Dot Foundation, and the Vail Health Foundation among others. She was named as a 2025 Rising Star by Genomics Press for her work in mental health assessment innovation. Roman Palitsky Roman Palitsky, MDiv, Ph.D. is Director of Research Projects for Emory Spiritual Health and a Research Psychologist for Emory University School of Medicine. His research program investigates the pathways through which culture and health interact by examining the biological, psychological, and social processes that constitute these pathways. His areas of interest include biopsychosocial determinants in cardiovascular health, chronic pain, and grief. In collaboration with Emory Spiritual Health, his research addresses cultural and existential topics in healthcare such as religion, spirituality, and the way people find meaning in suffering, as they relate to health and illness. His work has also focused on the role of religious and existential worldviews in mindfulness-based interventions, as well as implementation and cultural responsiveness of these interventions. Dr. Palitsky's academic training includes a PhD in Clinical Psychology from the University of Arizona with a concentration in Behavioral Medicine/Health Psychology, and a Master of Divinity from Harvard University. He completed clinical internship in the behavioral medicine track at Brown University Warren Alpert Medical School, where he also completed a postdoctoral fellowship. Deanna and Roman were in town attending and speaking at the 2025 SSSR Conference, Society for the Scienific Study of Religion. And as you will hear, we get deep into the spirit of sauna, a spiritual connection we allow ourselves to have, presented to us through the wonderfulness of time on the bench and chilling out in the garden, all misty wet with rain.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Step Accumulation Patterns and Risk for Cardiovascular Events andMortality Among Suboptimally Active Adults – Annals of Internal Medicine 2025.  Discussion by:Guest:Kathryn Donnelly, DO Resident - Family Medicine Residency ProgramJefferson Health - Abington2. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Obesity – The New England Journal of Medicine 2025. Discussion by:Guest:Ajay Rau, MDChief - Section of Endocrinology, Diabetes and Metabolism Lewis Katz School of Medicine at Temple University3. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. New England Journal Of Medicine 2025.  Discussion by: Guest:Jasmin Walker, MD Resident – Family Medicine Residency Program Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

As we age, we can develop a higher risk for dementia and Alzheimer's disease. It may even run in our families for some of us. But hope is not lost: About half of dementia cases are potentially preventable. Host Cristina Quinn walks us through the U.S. POINTER study led by Laura Baker, professor of gerontology and geriatrics at Wake Forest School of Medicine. This study is considered the largest clinical trial examining how simple lifestyle changes like eating healthier, staying socially engaged and moving more can slow down cognitive decline. Cristina also speaks with neurologist Monica Parker from Emory University School of Medicine. Read more about Baker's work with the U.S. POINTER study here. For more on Parker's work, visit the Emory Healthy Brain Study. For more on ways to reduce your risk of dementia, check out some of The Post's reporting:Want to keep your brain sharp as you age? Science may have a recipe,4 vaccines linked to a lower risk of dementiaWant to lower your risk of dementia? Here's what the science saysNo amount of alcohol is safe, at least for dementia risk, study findsSubscribe to The Washington Post or connect your subscription in Apple Podcasts.

Within the next few decades, rising sea levels could wipe some small Pacific Island nations off the face of the earth. The prospect that the physical territory of countries such as Kiribati and Tuvalu is no longer habitable raises the prospect that their nationals could lose their citizenship, becoming stateless. It also poses profound questions for international law and the obligations of other countries. How likely is this possible outcome, and what can countries do to protect their sovereignty and their citizens? Join our discussion with Mark Nevitt, an international law scholar at the Emory University School of Law.

Within the next few decades, rising sea levels could wipe some small Pacific Island nations off the face of the earth. The prospect that the physical territory of countries such as Kiribati and Tuvalu is no longer habitable raises the prospect that their nationals could lose their citizenship, becoming stateless. It also poses profound questions for international law and the obligations of other countries. How likely is this possible outcome, and what can countries do to protect their sovereignty and their citizens? Join our discussion with Mark Nevitt, an international law scholar at the Emory University School of Law.

Fluid overload is a common problem in critically ill patients. In this episode, Dr. Sergio Zanotti discuss recognizing and managing fluid overload in the ICU with guest Dr. Michael J. Connor, Jr., a practicing intensivist and nephrologist. Dr. Connor is a Professor and Senior Physician of Critical Care Medicine & Nephrology at the Divisions of Pulmonary, Allergy, Critical Care, and Sleep Medicine and Renal Medicine at Emory University School of Medicine. Additionally, he serves as the director of critical care nephrology at the Emory Critical Care Center at Grady Memorial Hospital. Additional resources European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: Part 3- fluid removal at de-escalation phase. Intensive Care Med 2025: https://pubmed.ncbi.nlm.nih.gov/40828463/ Optimizing Fluid Therapy in the Critically Ill. International Fluid Academy website – 2025: https://www.fluidacademy.org/2025/01/17/optimising-fluid-therapy-in-the-critically-ill-introduction-to-7d/ Fluid overload in the ICU: evaluation and management. R. Claure-Del Granado and R. L. Mehta. BMC Nephrology 2016: https://pubmed.ncbi.nlm.nih.gov/27484681/ Books and music mentioned in this episode: Think Again: The Power of Knowing What You Don't Know. By Adam Grant: https://bit.ly/4gZvz9c RUSHMERE. By Mumford & Sons: https://bit.ly/473FzKc

While genetic testing has replaced muscle biopsy in the diagnosis of many genetic myopathies, clinical assessment and the integration of clinical and laboratory findings remain key elements for the diagnosis and treatment of muscle diseases. In this episode, Casey Albin, MD, speaks with Margherita Milone, MD, PhD, FAAN, FANA, author of the article “A Pattern Recognition Approach to Myopathy” in the Continuum® October 2025 Muscle and Neuromuscular Junction Disorders issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Milone is a professor of neurology and the director of the Muscle Pathology Laboratory at Mayo Clinic College of Medicine and Science in Rochester, Minnesota. Additional Resources Read the article: A Pattern Recognition Approach to Myopathy Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Albin: Hello, this is Dr Casey Albin. Today I'm interviewing Dr Margherita Milone on her article on a pattern recognition approach to myopathy, which appears in the October 2025 Continuum issue on muscle and neuromuscular junction disorders. Welcome to the podcast, Dr Milone. Thank you so much for joining us. I'll start off by having you introduce yourself to our listeners. Dr Milone: Hello Casey, thank you so much for this interview and for bringing the attention to the article on muscle diseases. So, I'm Margherita Milone. I'm one of the neuromuscular neurologists at Mayo Clinic in Rochester. I have been interested in muscle disorders since I was a neurology resident many years ago. Muscle diseases are the focus of my clinical practice and research interest. Dr Albin: Wonderful. Thank you so much. When I think about myopathies, I generally tend to think of three large buckets: the genetic myopathy, the inflammatory myopathies, and then the necrotizing myopathies. Is that a reasonable approach to conceptualizing these myopathies? Dr Milone: Yeah, the ideology of the myopathies can be quite broad. And yes, we have a large group of genetic muscle diseases, which are the most common. And then we have immune-mediated muscle diseases, which include inflammatory myopathies as well as some form of necrotizing myopathies. Then we have some metabolic myopathies, which could be acquired or could be genetic. And then there are muscle diseases that are due to toxins as well as to infection. Dr Albin: Wow. So, lots of different etiologies. And that really struck me about your article, is that these can present in really heterogeneous ways, and some of them don't really read the rule book. So, we have to have a really high level of suspicion, for someone who's coming in with weakness, to remember to think about a myopathy. One of the things that I like to do is try to take us through a little bit of a case to sort of walk us through how you would approach if someone comes in. So, let's say you get, you know, a forty-year-old woman, and she's presenting with several months of progressive weakness. And she says that even recently she's noted just a little bit of difficulty swallowing. It feels to her like things are getting stuck. What are some of the things when you are approaching the history that would help you tease this to a myopathy instead of so many other things that can cause a patient to be weak? Dr Milone: Yes. So, as you mentioned, people who have a muscle disease have the muscle weakness often, but the muscle weakness is not just specific for a muscle disease. Because you can have a mass weakness in somebody who has a neurogenic paralysis. The problem with diagnosis of muscle diseases is that patients with these disorders have a limited number of symptom and sign that does not match the large heterogeneity of the etiology. So, in someone who has weakness, that weakness could represent a muscle disease, could represent an anterior horn cell disease, could represent a defect of neuromuscular junction. The clinical history of weakness is not sufficient by itself to make you think about a muscle disease. You have to keep that in the differential diagnosis. But your examination will help in corroborating your suspicion of a muscle disease. Let's say if you have a patient, the patient that you described, with six months' history of progressive weakness, dysphagia, and that patient has normal reflexes, and the patient has no clinical evidence for muscle fatigability and no sensory loss, then the probability that that patient has a myopathy increases. Dr Albin: Ah, that's really helpful. I'm hearing a lot of it is actually the lack of other findings. In some ways it's asking, you know, have you experienced numbness and tingling? And if not, that's sort of eliminating that this might not be a neuropathy problem. And then again, that fatigability- obviously fatigability is not specific to a neuromuscular junction, but knowing that is a hallmark of myasthenia, the most common of neuromuscular disorders. Getting that off the table helps you say, okay, well, it's not a neuromuscular junction problem, perhaps. Now we have to think more about, is this a muscle problem itself? Are there any patterns that the patients describe? I have difficulty getting up from a chair, or I have difficulty brushing my hair. When I think of myopathies, I historically have thought of, sort of, more proximal weakness. Is that always true, or not so much? Dr Milone: Yeah. So, there are muscle diseases that involve predominantly proximal weakness. For example, the patient you mentioned earlier could have, for example, an autoimmune muscle disease, a necrotizing autoimmune myopathy; could have, perhaps, dermatomyositis if there are skin changes. But a patient with muscle disease can also present with a different pattern of weakness. So, myopathies can lead to this weakness, and foot drop myopathies can cause- can manifest with the weakness of the calf muscles. So, you may have a patient presenting to the clinic who has no the inability to stand on tiptoes, or you may have a patient who has just facial weakness, who has noted the difficulty sealing their lips on the glasses when they drink and experiencing some drooling in that setting, plus some hand weakness. So, the muscle involved in muscle diseases can vary depending on the underlying cause of the muscle disease. Dr Albin: That's really helpful. So, it really is really keeping an open mind and looking for some supporting features, whether it's bulbar involvement, extraocular eye muscle involvement; looking, you know, is it proximal, is it distal? And then remembering that any of those patterns can also be a muscle problem, even if sometimes we think of distal being more neuropathy and proximal myopathy. Really, there's a host of ranges for this. I really took that away from your article. This is, unfortunately, not just a neat way to box these. We really have to have that broad differential. Let me ask another question about your history. How often do you find that patients complain of, sort of, muscular cramping or muscle pain? And does that help you in terms of deciding what type of myopathy they may have? Dr Milone: Many patients with muscle disease have muscle pain. The muscle pain could signal a presence of inflammation in skeletal muscle, could be the result of overuse from a muscle that is not functioning normally. People who have myotonia experience muscle stiffness and muscle pain. Patients who have a metabolic myopathy usually have exercise-induced muscle pain. But, as we know, muscle pain is also very nonspecific, so we have to try to find out from the patient in what setting the pain specifically occurs. Dr Albin: That's really helpful. So, it's asking a little bit more details about the type of cramping that they have, the type of pain they may be experiencing, to help you refine that differential. Similarly, one of the things that I historically have always associated with myopathies is an elevation in the CK, or the creatinine kinase. How sensitive and specific is that, and how do you as the expert sort of take into account, you know, what their CK may be? Dr Milone: So, this is a very good point. And the elevation of creatine kinase can provide a clue that the patient has a muscle disease, but it is nonspecific for muscle disease because we know that elevation of creatine kinase can occur in the setting of a neurogenic process. For example, we can see elevation of the creatine kinase in patients who have ALS or in patients who have spinal muscular atrophy. And in these patients---for example, those with spinal muscular atrophy---the CK elevation can be also of significantly elevated up to a couple of thousand. Conversely, we can have muscle diseases where the CK elevation does not occur. Examples of these are some genetic muscle disease, but also some acquired muscle diseases. If we think of, for example, cases where inflammation in the muscle occurs in between muscle fibers, more in the interstitium of the muscle, that disease may not lead to significant elevation of the CK. Dr Albin: That's super helpful. So, I'm hearing you say CK may be helpful, but it's neither completely sensitive nor completely specific when we're thinking about myopathic disorders. Dr Milone: You are correct. Dr Albin: Great. So, coming back to our patients, you know, she says that she has this dysphasia. How do bulbar involvement or extraocular eye movement involvement, how do those help narrow your differential? And what sort of disorders are you thinking of for patients who may have that bulbar or extraocular muscle involvement? Dr Milone: Regarding dysphagia, that can occur in the setting of acquired myopathies relatively frequent; for example, in inclusion body myositis or in other forms of inflammatory myopathy. Your patient, I believe, was in their forties, so it's a little bit too young for inclusion body myositis. Involvement of the extraocular muscles is usually much more common in genetic muscle diseases and much less frequent in hereditary muscle disease. So, if there is involvement of the extraocular muscles, and if there is a dysphagia, and if there is a proximal weakness, you may think about oculopharyngeal muscular dystrophy, for example. But obviously, in a patient who has only six months of history, we have to pay attention of the degree of weakness the patient has developed since the symptom onset. Because if the degree of weakness is mild, yes, it could still be a genetic or could be an acquired disease. But if we have a patient who, in six months, from being normal became unable to climb stairs, then we worry much more about an acquired muscle disease. Dr Albin: That's really helpful. So, the time force of this is really important. And when you're trying to think about, do I put this in sort of a hereditary form of muscle disease, thinking more of an indolent core, something that's going to be slowly progressive versus one of those inflammatory or necrotizing pathologies, that's going to be a much more quick onset, rapidly progressive, Do I have that right? Dr Milone: In general, the statement is correct. They tend, acquired muscle disease, to have a faster course compared to a muscular dystrophy. But there are exceptions. There have been patients with immune mediated necrotizing myopathy who have been misdiagnosed as having limb-girdle muscular dystrophy just because the disease has been very slowly progressive, and vice versa. There may be some genetic muscle diseases that can present in a relatively fast way. And one of these is a lipid storage myopathy, where some patients may develop subacutely weakness, dysphagia, and even respiratory difficulties. Dr Albin: Again, I'm hearing you say that we really have to have an open mind that myopathies can present in a whole bunch of different ways with a bunch of different phenotypes. And so, keeping that in mind, once you suspect someone has a myopathy, looking at the testing from the EMG perspective and then maybe laboratory testing, how do you use that information to guide your work up? Dr Milone: The EMG has a crucial role in the diagnosis of muscle diseases. Because, as we said earlier, weakness could be the result of muscle disease or other form of neuromuscular disease. If the EMG study will show evidence of muscle disease supporting your diagnostic hypothesis, now you have to decide, is this an acquired muscle disease or is this a genetic muscle disease? If you think that, based on clinical history of, perhaps, subacute pores, it is more likely that the patient has an acquired muscle disease, then I would request a muscle biopsy. The muscle biopsy will look for structural abnormalities that could help in narrowing down the type of muscle disease that the patient has. Dr Albin: That's really helpful. When we're sending people to get muscle biopsies, are there any tips that you would give the listeners in terms of what site to biopsy or what site, maybe, not to biopsy? Dr Milone: This is a very important point. A muscle biopsy has the highest diagnostic yield if it's done in a muscle that is weak. And because muscle diseases can result in proximal or distal weakness, if your patient has distal weakness, you should really biopsy a distal muscle. However, we do not wish to biopsy a muscle that is too weak, because otherwise the biopsy sample will result just in fibrous and fatty connected tissue. So, we want to biopsy a muscle that has mild to moderate weakness. Dr Albin: Great. So, a little Goldilocks phenomenon: has to be some weak, but not too weak. You got to get just the right feature there. I love that. That's a really good pearl for our listeners to take. What about on the flip side? Let's say you don't think it's an acquired a muscular disease. How are you handling testing in that situation? Dr Milone: If you think the patient has a genetic muscle disease, you pay a lot of attention to the distribution of the weakness. Ask yourself, what is the best pattern that represent the patient's weakness? So, if I have a patient who has facial weakness, dysphagia, muscle cramping, and then on examination represent myotonia, then at that point we can go straight to a genetic test for myotonic dystrophy type one. Dr Albin: That's super helpful. Dr Milone: So, you request directly that generic test and wait for the result. If positive, you will have proof that your diagnostic hypothesis was correct. Dr Albin: You're using the genetic testing to confirm your hypothesis, not just sending a whole panel of them. You're really informing that testing based on the patient's pattern of weakness and the exam findings, and sometimes even the EMG findings as well. Is that correct? Dr Milone: You are correct, and ideally, yes. And this is true for certain muscle diseases. In addition to myotonic dystrophy type one, for example, if you have a patient who has fascial scapulohumeral muscular weakness, you can directly request a test for FSHD. So, the characterization of the clinical phenotype is crucial before selecting the genetic test for diagnosis. Dr Albin: Wonderful. Dr Milone: However, this is not always possible, because you may have a patient who has just a limb-girdle weakness, and the limb-girdle weakness can be limb-girdle muscular dystrophy. But we know that there are many, many types of limb-girdle muscular dystrophies. Therefore, the phenotype is not sufficient to request specific genetic tests for one specific form of a limb-girdle muscular dystrophy. And in those cases, more complex next-generation sequencing panels have a higher chance of providing the answer. Dr Albin: Got it, that makes sense. So, sometimes we're using a specific genetic test; sometimes, it is unfortunate that we just cannot narrow down to one disease that we might be looking for, and we may need a panel in that situation. Dr Milone: You are correct. Dr Albin: Fantastic. Well, as we wrap up, is there anything on the horizon for muscular disorders that you're really excited about? Dr Milone: Yes, there are a lot of exciting studies ongoing for gene therapy, gene editing. So, these studies are very promising for the treatment of genetic muscle disease, and I'm sure there will be therapists that will improve the patient's quality of life and the disease outcome. Dr Albin: It's really exciting. Well, thank you again. Today I've been interviewing Dr Margarita Malone on her article on a pattern recognition approach to myopathy, which appears in the October 2025 Continuum issue on muscle and neuromuscular junction disorders. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining us today. And thank you, Dr Milone. Dr Milone: Thank you, Casey. Very nice chatting with you about this. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity – The New England Journal of Medicine 2025. Discussion by:Guest:Anupryia Grover-Wenk, DOResident - Family Medicine Residency ProgramJefferson Health - Abington2. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2Diabetes. – The New England Journal of Medicine 2025.Discussion by: Guest:Samantha Traslaviña, DOResident– Family Medicine Residency ProgramJefferson Health – Abington3. Cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial. Lancet Rheumatology 2025. Discussion by: Guest:Sean Cleary, DO Resident– Family Medicine Residency Program Jefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Kate Mihevc Edwards used to run for no particular reason, except that she loved it. Then, she discovered the world of competitive running in college and ran numerous half marathons and 13 marathons -- three of which were Boston. On her son's first birthday, she went for a run, like always. As she returned home, her heart rate skyrocketed to 300 bpm. She was later diagnosed with a rare heart condition that sidelined any hope of returning to running.Meanwhile, she left her career in marketing and studied to be a physical therapist and board-certified orthopedic specialist who practices running medicine. She has over 15+ years of experience working with high performers, CEOs, runners and athletes of all levels, from recreational athletes to Olympians. She is the founder of Precision Performance Running Medicine Clinic in Atlanta, GA, the RUNsource app and co-host of the Interdisciplinary Case MIles Podcast. She is an integral part of the multidisciplinary team supporting Atlanta Track Club Elite. Dr. Edwards has served as adjunct faculty at Emory University School of Medicine and is a published author and speaker, contributing extensively to education, research and the advancement of sports medicine for runners. Follow her at: @katemihevcedwards @FBrunsource @precisionpt_atl

Are you considering expanding your IR practice into pain management services? Get the download from someone who's done it already. In this episode of BackTable MSK, Dr. Sean Maratto from Philadelphia's Jefferson Health Network is joined by guest Dr. Junjian Huang from Emory University School of Medicine to discuss the intricacies of building a pain management practice within the interventional radiology space. ---This podcast is supported by an educational grant from Medtronic.---SYNPOSISDr. Huang shares his career journey, highlighting his shift towards pain palliation. The conversation covers a range of topics including procedural insights, patient management strategies, navigating institutional politics, and future trends in orthopedic IR. Dr. Huang emphasizes the importance of balancing patient care with building robust referral networks, and shares valuable advice for budding interventional radiologists.---TIMESTAMPS00:00 - Introduction02:20 - What's Your Why? Why Pain Intervention? 12:52 - Building a Complex Pain Management Practice24:47 - Marketing a Service Line30:57 - Patient Impact from Pain Management Services39:53 - Recommendations and Indications for Cryoneurolysis and BVNA 45:36 - Post-Procedure Follow-up and Psychosomatic Pain Guidance52:35 - Insight to the Future of Interventional Pain and Final Thoughts---RESOURCESDr. Junjian Huang, MDhttps://med.emory.edu/directory/profile/?u=JHUAN22 Dr. Sean Maratto, MDhttps://www.jeffersonhealth.org/find-a-doctor/m/maratto-sean-a

About this episode: Last week, Dr. Debra Houry was testifying before Congress. Today, she's talking with Dr. Josh Sharfstein on Public Health On Call. In this episode: Dr. Houry reflects on her time at the CDC, the drastic changes at the agency under Health and Human Services Secretary Robert F. Kennedy Jr., and what she hopes her testimony can do to uphold quality public health. Guest: Dr. Debra Houry, MPH, most recently served as the Chief Medical Officer and Deputy Director for Program and Science at the CDC. She has also worked as a professor at both the Emory University School of Medicine and the Rollins School of Public Health, and as an emergency department physician. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Testimony from Debra Houry, M.D., M.P.H.—Senate Committee on Health, Education, Labor, and Pensions Senior CDC officials resign after Monarez ouster, cite concerns over scientific independence—CBS News A Brief Update: CDC in Crisis—Public Health On Call (September 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

When the rule of law comes under attack, who speaks up? In Georgia, more than 400 lawyers have come together to form Georgia Lawyers for the Rule of Law — the only statewide group dedicated to defending judges, lawyers, and the integrity of our justice system. In this powerful episode of See You In Court, hosts Robin Frazer Clark and Lester Tate welcome Seth Kirschenbaum and Lynne Borsuk to share: Why they launched this nonpartisan effort How threats against judges and law firms erode confidence in justice What ordinary citizens and lawyers alike can do to protect due process Their message is clear: justice is not partisan — it's the foundation of our democracy.

In this episode, Dr. Russell Berman sits down with Dr. Sandra Wong, Dean of Emory University School of Medicine, and Dr. David Linehan, Dean of University of Rochester School of Medicine and Dentistry. Together, they share what it means to step beyond the operating room and into the role of shaping the future of medical education.  From leading surgical oncology programs to leading entire medical schools, Drs. Wong and Linehan discuss their journeys, the challenges of balancing clinical, research, and administrative responsibilities, and how surgical oncologists are uniquely positioned to guide the next generation of physicians.

Tics are movements or sounds that are quick, recurrent, and nonrhythmic. They fluctuate over time and can be involuntary or semivoluntary. Although behavioral therapy remains the first-line treatment, modifications to comprehensive behavioral intervention have been developed to make treatment more accessible. In this episode, Casey Albin, MD, speaks with Jessica Frey, MD, author of the article “Tourette Syndrome and Tic Disorders” in the Continuum® August 2025 Movement Disorders issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Frey is an assistant professor of neurology, Movement Disorders Fellowship Program Director, and Neurology Student Clerkship Director at the Rockefeller Neuroscience Institute in the department of neurology at West Virginia University in Morgantown, West Virginia. Additional Resources Read the article: Tourette Syndrome and Tic Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Transcript Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Albin: Hi all, this is Dr Casey Albin. Today I'm interviewing Dr Jessica Frey about her article Tourette Syndrome and Tic Disorders, which appears in the August 2025 Continuum issue on movement disorders. Dr Frey, thank you so much for being here, and welcome to the podcast. I'd love for you to briefly introduce yourself to our audience. Dr Frey: Thank you for having me here today. My name is Jessica Frey, and I am a movement disorder specialist at West Virginia University. I'm also the movement disorder fellowship director, as well as the neurology clerkship student director. Dr Albin: Dr. Frey, I feel like this was one of the things I actually had no exposure to as a resident. For trainees that kind of want to get a better understanding of how these are managed, what kind of counseling you do, what kind of interventions you're using, how can they get a little bit more exposure? Dr Frey: That's a great question, and I actually had a similar experience to you. I did not see that many patients with Tourette syndrome while I was in my residency training. I got a lot more exposure during my fellowship training, and that's when I actually fell in love with that patient population, caring for them, seeing them be successful. I think it depends on the program that you're in. During the pediatric neurology rotation might be your best bet to getting exposure to patients with Tourette syndrome, since a lot of them are going to be diagnosed when they're quite young, and sometimes they'll even continue to follow through young adulthood in the pediatric neurology clinic. However, up to 20% of patients with Tourette syndrome will have persistent tics during adulthood. And so, I think it is important for neurology trainees to understand how to manage them, understand what resources are out there. So, if you have an interest in that, absolutely try to follow either in the pediatric neurology department, or if you have a movement disorder program that has a Tourette clinic or has a movement disorder specialist who has an interest in Tourette syndrome, definitely try to hang out with them. Get to know that patient population, and educate yourself as much as you're able to educate the patients as well. Dr Albin: Yeah, I think that's fantastic advice. You wrote a fantastic article, and it covers a lot of ground. And I think let's start at some of the basics. When I think of Tourette syndrome and tics, I think of Tourette syndrome having tics, but maybe not all patients who have tics have Tourette syndrome. And so, I was wondering, A, if you could confirm that's true; and then could you tell us a little bit about some of the diagnostic criteria for each of these conditions? Dr Frey: Sure. So, a tic is a phenomenological description. So basically, what you're seeing is a description of a motor or phonic tic, which is a particular type of movement disorder. Tourette syndrome is a very specific diagnosis, and the diagnostic criteria for Tourette syndrome at this point in time is that you need to have had at least one phonic tic and two or more motor tics over the course of at least a year before the age of eighteen. Dr Albin: Got it. So, there's certainly more specific and a lot more criteria for having Tourette syndrome. I was struck in reading your article how many myths there are surrounding Tourette syndrome and tic disorders kind of in general. What's known about the pathophysiology of Tourette syndrome, and what are some common misconceptions about patients who have this disorder? Dr Frey: Yeah, so I think that's a really excellent question because for so many years, Tourette syndrome and tic disorders in general were thought to be psychogenic in origin, even dating back to when they were first described. The history of Tourette syndrome is quite interesting in that, when Tourette---who, you know, it's named after---was working with Charcot, a lot of the initial descriptors were of actual case reports of patients who had more psychogenic descriptions, and eventually they became known as tic disorders as well. It wasn't until the discovery of Haldol and using Haldol as a treatment for tic disorders that people started to change their perception and say, okay, maybe there is actually a neurologic basis for Tourette syndrome. So, in terms of the pathophysiology, it's not completely known, but what we do know about it, we think that there is some sort of hyperactivity in the corticostriatal-thalamocortical circuits. And we think that because of this hyperactivity, it leads to the hyperactive movement disorder. We think similar circuitry is involved in conditions like OCD, or obsessive compulsive disorder; as well as ADHD, or attention deficit hyperactivity disorder. And because of that, we actually do tend to see an overlap between all three of these conditions in both individuals and families. Dr Albin: And hearing all of that, does this all come back to, sort of, dopamine and, sort of, behavioral motivation, or is it different than that? Dr Frey: It's probably more complex than just dopamine, but there is the thought that dopamine does play a role. And even one of the hypotheses regarding the pathophysiology is actually that these tics might start as habits, and then when the habits become more common, they actually reshape the dopaminergic pathways. And each time a tic occurs, there's a little bit of a dopaminergic reward. And so over time, that reshapes those hyperactive pathways and changes the actual circuitry of the brain, leading it to be not just a habit but part of their neurologic makeup. Dr Albin: It's fascinating to hear how that actually might play into our neural circuitry and, over time, rewire our brain. Fascinating. I mean, this is just so interesting how movement disorders play into such behavioral regulation and some comorbid conditions like ADHD and OCD. I thought it would be really helpful, maybe, to our listeners to kind of think through a case that I suspect is becoming more common. So, if it's okay with you, I'll present sort of a hypothetical. Dr Frey: Absolutely. Dr Albin: This is a father bringing in his seventeen-year-old daughter. She's coming into the clinic because she's been demonstrating, over the past four to six weeks, some jerking movement in her right arm. And it's happened multiple times a day. And it was a pretty sudden onset. She had not had any movement like this before, and then several weeks ago, started moving the right hand. And then it became even more disruptive: her right leg was involved, she had some scrunching her face. This is all happening at a time where she was dealing with some stress, maybe a little bit of applications around college that she was having a lot of anxiety about. How do you sort of approach this case if this is someone who comes to your office? Dr Frey: Sure. So, I think the first thing that you want to get is a good solid history, trying to understand, what is the origin of these abnormal movements and what led to the abnormal movements. Now, a key thing here is that in Tourette syndrome, and most physiologic tic syndromes, there's a pretty early onset. So, in Tourette syndrome, the expected age of onset is between the ages of five and seven years old. So, to have kind of acute new abnormal movements as a seventeen-year-old would be very unusual for a new-onset diagnosis of Tourette syndrome. However, there's a couple of things from the history that could help you. One would be, were there ever tics in the past? Because sometimes, when you think retrospectively, a lot of these patients might have had a simple eye-blinking tic or a coughing tic when they were a child. And perhaps they did have Tourette syndrome, a very mild case of it. But because the tics were never that pronounced, they never went to see anyone about it and it was never known that they had Tourette syndrome in the first place. If there is no history like that and the movements are completely new, out of the blue, of course you want to rule out anything acute that could be going on that could be causing that. Looking at the phenomenology of the movements can also be very helpful. When you're looking at abnormal tic movements, you would expect most cases of something like Tourette syndrome to occur first in the midline and go in a rostrocoidal distribution. So, you mostly see things happening with eye blinking, throat clearing, sniffling, neck snapping. These are some of the immediate tics that start to happen. We also usually start to see simple tics, as opposed to complex tics, at the beginning. Now, over the course of time, many patients do develop more complex tics that might involve the arms or the extremities, but that would be unusual to see this as a presenting feature of new-onset Tourette syndrome. Dr Albin: Got it. So, I'm hearing that the history really matters and that sometimes, like those, like, first-onset seizures, I imagine as a neurointensivist, we see a lot of patients who've had seizures who think that they're presenting the first time. And then we go back and we say, well, actually they have had some abnormal movements at night. Sounds like it's very similar with these movement disorders where you have to really go back and ask, well, was there some sniffling? Did they go through a phase where they were grunting frequently? Because I can imagine that many children make those behaviors, and that it may not have registered as something that was cause for concern. Dr Frey: Absolutely. Dr Albin: And then the other thing I heard from you was that the phenomenology really matters and that there is a typical presentation, starting from sort of the face and working the way down. And that can be really helpful. But in this case, the family is quite clear. No, no, no. She's never had movements like this before. This is- nothing like this. We promise you, did not go through a phase where she was coughing or blinking, or, this is all totally new. And the phenomenology, they say, no, no, she did not start with blinking. It definitely started in the arm and then progressed in its complex movements. So, knowing that about her, how does that sort of shape how you move forward with the diagnosis? Dr Frey: Yeah. So, really good question. And this is something that I think really peaked during the Covid-19 pandemic. We saw an influx of patients, especially teenage girls or young adult girls, who basically would come in and have these new, acute-onset, abnormal movements. We weren't sure what to call them initially. There was some discussion of calling them “explosive tic disorder” and things like that. A lot of these actually looked very similar to psychogenic nonepileptic seizures, where they would come into the emergency department and have many abnormal movements that were so severe, that they were having a “tic attack” and couldn't stop the abnormal movements from occurring. And we saw so many of these cases during the Covid-19 pandemic that it eventually became known as a distinctive diagnostic criteria with the name of “functional ticlike behavior”, or FTLB. When we think about functional ticlike behavior, we think that these tics are driven more by anxiety and stress. A lot of times, the backstory of these patients, they were in a very stressful situation, and that's when the abnormal movement started. So, a very similar kind of backstory to patients that might develop psychogenic nonepileptic seizures. These tics were popularized, for lack of a better term, via social media during the Covid-19 pandemic. One article is out there that even has called these functional ticlike behaviors as “a pandemic within a pandemic”, because there was such a strong showing of ticlike behavior in the clinics during the Covid-19 pandemic. Although social media was thought to play a big role in these functional ticlike behaviors, we think that there's probably a little bit more complexity and nuance to why these functional ticlike behaviors develop. There is probably a little bit of a genetic predisposition. There's probably some other psychosocial factors at play. And when we see cases like this, the best thing that you can do is educate your patients about the differences between functional ticlike behaviors and tics that we see associated with conditions like Tourette syndrome. And then the best types of treatments that we have seen thus far are treating any underlying stressors, if any of those exist, as well as cognitive behavioral therapy has been shown to be somewhat helpful. As the Covid-19 pandemic has wound down, we have actually seen a lot less cases in our clinic. And one reason we think is less stressors, less uncertainty for the future, which we think was a driving precipitant of some of these cases. But it also is not as popularized in the media as well. There were a lot of TikTok users in particular, which lent itself to the name “TikTok tic”. These videos are not as viewed or not as popular as they were during the Covid-19 pandemic. One reason being that because we are not all relegated to our homes, constantly looking to online sources of information---just in general, we have kind of not been on the Internet as much as we were during the Covid-19 pandemic---as a society as a whole. Dr Albin: This is really fascinating how the environmental milieu, for lack of a better word, like, really influenced how patients were experiencing, sort of, functional neurologic disorders. In your article you describe really these three baskets of primary tic---which can then be a part of Tourette syndrome---,functional ticlike behaviors---which really were a unique manifestation of stress and anxiety specifically during the Covid-19 pandemic---, and then tics as a manifestation of some either different underlying etiology or medication side effect. So, when do you get concerned about that secondary etiology? Dr Frey: So secondary tics can occur in a variety of instances. I think some of the more common examples would be in genetic disorders. So, Huntington's disease is a really good example. I think we all associate chorea with Huntington's disease. That's probably the most commonly associated phenomenology that we see with Huntington's disease. But we can see a variety of movement disorders in Huntington's, and one of them is tics. So, when we see tics in association with other types of movement disorders, we should be thinking about a possible genetic etiology. If we see tics in association with other neurologic symptoms, such as seizures or cognitive changes, we should be thinking that this is something besides a primary tic disorder. You also mentioned medication use, and it's really important to think about tardive tics. I know we often think about tardive dyskinesia, and the first kind of phenomenology that jumps into our brain is usually chorea because it's those abnormal lip movements, finger movements, toe movements that we see after a patient has been on, for example, an antipsychotic or an antiemetic that has antidopaminergic properties. However, we can see a variety of abnormal movement disorders that occur secondary to antidopaminergic medications, especially after abrupt withdrawal of these antidopaminergic medications. And tics are one of them. There have been cases reported where people that have tardive tics will still report that they have a premonitory urge, as well as a sense of relief after their tics. So, it actually can seem very similar to Tourette syndrome and the tics that people with Tourette syndrome experience on a regular basis. The key here is that the treatment might differ because if it's due to an antidopaminergic medication or abrupt withdrawal of that antidopaminergic medication, you might need to treat it a little bit differently than you would otherwise. Dr Albin: I love that you bring in, it's not just looking at their specific movement disorder that they may be coming to clinic with, that tic disorder, but are there other movement disorders? Has there been a change in their medication history? Have they had cognitive changes? So really emphasizing the importance of that complete and comprehensive neurologic history, neurologic physical exam, to really get the complete picture so that it's not honing in on, oh, this is a primary tic. That's all there is to it, because it could be so much more. I know we're getting close to sort of the end of our time together, but I really wanted to switch to end on talking about treatment. And your article does such a beautiful job of talking about behavioral interventions and really exciting new medical interventions. But I would like to, if you don't mind, have you focus on, what behavioral counseling and what education do you provide for patients and their families? Because I imagine that the neurologist plays a really important role in educating the patient and their family about these disorders. Dr Frey: Absolutely. When we think about treatment, one of the most important things you can do for patients with Tourette syndrome or other primary tic disorders is educate them. This remains true whether it's a primary tic disorder that we see in Tourette syndrome or the functional ticlike behavior that we've discussed here. A lot of times, because there is such a stigma against people with tic disorders and Tourette syndrome, when they hear that they have Tourette syndrome or they are diagnosed with that, sometimes that can be an upsetting diagnosis. And sometimes you have to take time explaining what exactly that means and debunking a lot of the myths that go along with the stigmas associated with Tourette syndrome. I think a lot of times people are under the false assumption that people with Tourette syndrome cannot lead normal lives and cannot hold down jobs and cannot be productive members of society. None of that is true. Most of my patients have great lives, good quality of life, and are able to go about their day-to-day life without any major issues. And one of the reasons for that is we do have a lot of great treatment options available. Another important stigma to break down is that people with tic disorders are doing this for attention or doing this because they are trying to get something from someone else. That is absolutely false. We do think that the tics themselves are semivolitional because people with Tourette syndrome have some degree of control over their tics. They can suppress them for a period of time. But a lot of people with tic disorders and Tourette syndrome will describe their tics as if you're trying to hold onto a sneeze. And you can imagine how uncomfortable it is to hold in a sneeze. We're all able to do it for a period of time, but it's much easier to just allow that sneeze to occur. And a lot of times that's what they are experiencing, too. So, although there is some degree of control, it's not complete control, and they're certainly not doing these tics on purpose or for attention. So that's another important myth to debunk when you're counseling patients and their families. I think the dynamic between young patients that are presenting with their parents or guardians, sometimes that dynamic is a little bit challenging because another faulty assumption is that parents feel they are responsible for having this happen to their child. There used to be a really strong sense that parents were responsible for the tics that occurred in their children, and that is also absolutely not true. Parenting has nothing to do with having the tics or not. We know that this is a neurodevelopmental disorder. The brain is indeed wired differently and it's important to counsel that with the parents, too, so that they understand what tools they need to be successful for their children as well. Dr Albin: I love that. So, it's a lot of partnership with patients and their families. I really like that this is just a wire different, and I hope over time that working together we as neurologists can help break down some of that stigmatization for these patients. This has been an absolutely phenomenal discussion. I have so enjoyed learning from your article. For the listeners out there, there are some really phenomenal tables that go into sort of how to approach this from the office perspective, how to approach it from the treatment perspective. So, thank you again, Dr Jessica Frey, for your article on Tourette syndrome and tic disorders, which appears in the August 2025 Continuum issue on movement disorders. Be sure to check out Continuum Audio episodes from this and other issues, and thank you so much to our listeners for joining us today. Dr Frey: Thank you for having me. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

In this important episode of Transmission Interrupted, host Jill Morgan is joined by a distinguished panel of experts to provide a comprehensive update on respiratory illness trends for the 2025 season. Dr. Ryan Maves (infectious diseases and critical care medicine, Wake Forest University), Dr. Kari Simonson (pediatric infectious diseases, University of Nebraska Medical Center), and Dr. John Horton (clinical affairs, gynecology and obstetrics, Emory University) share the latest data and evidence-based recommendations for healthcare providers and the public.The discussion covers the full spectrum of respiratory viruses currently impacting our communities, including influenza, RSV, COVID-19, and pertussis. The panel addresses the unique risks facing infants, children, pregnant individuals, older adults, and those with underlying health conditions. Listeners will gain valuable insight into current vaccine guidance, the role of updated testing strategies, and protective measures that go beyond vaccination—such as proper mask use, respiratory and hand hygiene, and the importance of source control and eye protection.This episode offers practical guidance for both healthcare workers and the public as we enter another busy respiratory virus season. Drawing on real-world experience and the latest research, our guests emphasize steps we can all take to reduce transmission, protect vulnerable populations, and maintain safety in both clinical and home settings.GuestsJohn Patrick Horton, MD, MBAVice Chair of Clinical Affairs for Gynecology and Obstetrics Emory UniversityDr. John Horton is the Vice Chair of Clinical Affairs for Emory University's Department of Gynecology and Obstetrics. He also serves as Emory Healthcare's Division Director for General Gynecology and Obstetrics, and Interim Operations Director for the Gynecologic Specialties Division. Additionally, Dr. Horton is the Director of the Obstetric Rapid Response Team at Emory Healthcare and is Associate Professor at the Emory University School of Medicine Department of Gynecology and Obstetrics. Ryan Maves, MD, FCCM, FCCP, FIDSAProfessor in Infectious Disease and Critical Care MedicineOffice of Global HealthWake Forest UniversityDr. Ryan Maves is a Professor of Medicine at the Wake Forest University School of Medicine in Winston-Salem, North Carolina, where he serves as medical director of transplant infectious diseases and as a faculty intensivist at North Carolina Baptist Hospital. A graduate of the University of Washington School of Medicine, he entered active duty in the U.S. Navy in 1999. He completed his residency in internal medicine and fellowships infectious diseases and critical care medicine at Naval Medical Center San Diego. During his military service, he served as the flight surgeon for Carrier Air Wing SEVENTEEN embarked onboard the USS George Washington (CVN-73), at the Naval Medical Research Unit No. 6 in Lima, Peru, conducting preclinical and clinical studies in antimicrobial drug resistance and vaccine development, as director of medical services at the NATO Role 3 Multinational Medical Unit at Kandahar Airfield, Afghanistan, and as ID division chief and fellowship director in San Diego. He retired from active duty in 2021 and joined the faculty at Wake Forest. He is the chair of the ABIM Critical Care Medicine Examination Board, co-chair of the SCCM Congress Program Committee, and Chair-Elect of the Chest Infections and Disaster Response Network in CHEST, as well as deputy editor for outreach for the journal CHEST and contributing editor for Critical Care Explorations. He is an author of over 150 scientific manuscripts, 15 textbook chapters, and 100 conference abstracts and invited lectures. He lives in Winston-Salem with his wife, Robin, whom he met in the traditional manner (in the ICU, next to a...

This episode's guest is Dr Rimona Afana. Rimona is a Romanian-Palestinian academic, as well as an activist and multimedia artist. Her research addresses war crimes, crimes against humanity, crimes against nature, and crimes against nonhuman animals. Her work has taken her to various institutions, including Emory University School of Law and Kennesaw State University in the US, where she was an Assistant Professor of Peace Studies. Among her other research projects, she is working on a book with the working title Ecocide/Speciesism: Rethinking Interdependence in the Anthropocene. In this episode, however, we discuss her forthcoming paper ‘The Invisible Victims of Israel's Genocide/Ecocide on Gaza: Crimes Against Nature and Nonhuman Animals', which is an invited contribution to the De Gruyter Handbook of Conflict Resolution and Peace. Listeners interested in reading the paper are invited to email Rimona for a copy. This will also allow them to check the sources for the facts and figures that Rimona mentions during the interview. The cover image is by Rimona, and features a homeless  kitten in Rafah, Gaza. In response to the quick questions, Rimona mentioned: The work of Richard Falk (https://doi.org/10.1177/096701067300400105) and Polly Higgins (https://shepheardwalwyn.com/product/eradicating-ecocide-second-edition/) on ecocide. The work of Richard Ryder (https://en.wikipedia.org/wiki/Richard_D._Ryder), Steve Sapontzis (https://en.wikipedia.org/wiki/Steve_F._Sapontzis), Steven Wise (https://en.wikipedia.org/wiki/Steven_M._Wise), and Piers Beirne (https://usm.maine.edu/directories/people/piers-beirne/) on animals. Her own work on ecocide (https://link.springer.com/rwe/10.1007/978-981-15-3877-3_33-1) and theriocide (https://vernonpress.com/book/1852). You can find Rimona/Rimona's work on LinkedIn (https://linkedin.com/in/rimonaafana/), ORCID (https://orcid.org/0009-0007-0871-3530), X (https://x.com/rimona_afana), and BSky (https://bsky.app/profile/rimona-afana.bsky.social). You can follow her Ecocide/Speciesism project on Facebook at http://www.facebook.com/ecocide.speciesism. Knowing Animals is proudly sponsored by the Animal Politics book series, from Sydney University Press. For more information about the series, see https://sydneyuniversitypress.com/collections/series-animal-politics.

ARFID is an eating disorder that often presents as extremely picky eating, but that can quickly turn serious. Caitlin Moscatello, author and contributor to New York Magazine, and William Sharp, director, Children's Multidisciplinary Feeding Program at Children's Healthcare of Atlanta; and associate Professor, Division of Autism and Related Disorders & Division of Pediatric Gastroenterology, Hepatology, and Nutrition in the Department of Pediatrics, Emory University School of Medicine, explain how to recognize signs and how treatment is evolving.